Prestige Consumer Healthcare (PBH) 10-Q 4 Aug 16 2017 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Jun. 30, 2016	Jul. 29, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	Prestige Brands Holdings, Inc.
Entity Central Index Key	1,295,947
Current Fiscal Year End Date	--03-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Jun. 30, 2016
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		52,915,673

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Revenues
Net sales	$ 208,770	$ 191,287
Other revenues	805	845
Total revenues	209,575	192,132
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	87,984	79,896
Gross profit	121,591	112,236
Operating Expenses
Advertising and promotion	27,635	26,422
General and administrative	19,457	17,589
Depreciation and amortization	6,832	5,720
Loss on sale of assets	55,453	0
Total operating expenses	109,377	49,731
Operating income	12,214	62,505
Other (income) expense
Interest income	(57)	(27)
Interest expense	21,184	21,911
Loss on extinguishment of debt	0	451
Total other expense	21,127	22,335
(Loss) income before income taxes	(8,913)	40,170
(Benefit) provision for income taxes	(3,382)	13,997
Net (loss) income	$ (5,531)	$ 26,173
(Loss) earnings per share:
Basic (in USD per share)	$ (0.10)	$ 0.50
Diluted (in USD per share)	$ (0.10)	$ 0.49
Weighted average shares outstanding:
Basic (in shares)	52,881	52,548
Diluted (in shares)	52,881	52,958
Comprehensive (loss) income, net of tax:
Currency translation adjustments	$ (5,824)	$ (405)
Total other comprehensive loss	(5,824)	(405)
Comprehensive (loss) income	$ (11,355)	$ 25,768

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016
Current assets
Cash and cash equivalents	$ 28,877	$ 27,230
Accounts receivable, net	88,437	95,247
Inventories	92,867	91,263
Deferred income tax assets	10,702	10,108
Prepaid expenses and other current assets	18,730	25,165
Assets held for sale	41,745	0
Total current assets	281,358	249,013
Property and equipment, net	15,080	15,540
Goodwill	356,525	360,191
Intangible assets, net	2,223,559	2,322,723
Other long-term assets	1,918	1,324
Total Assets	2,878,440	2,948,791
Current liabilities
Accounts payable	35,012	38,296
Accrued interest payable	9,216	8,664
Other accrued liabilities	55,913	59,724
Total current liabilities	100,141	106,684
Long-term debt
Principal amount	1,602,500	1,652,500
Less unamortized debt costs	(25,086)	(27,191)
Long-term debt, net	1,577,414	1,625,309
Deferred income tax liabilities	460,557	469,622
Other long-term liabilities	2,847	2,840
Total Liabilities	2,140,959	2,204,455
Commitments and Contingencies
Stockholders' Equity
Preferred stock - $0.01 par value; Authorized - 5,000 shares; Issued and outstanding - None	0	0
Common stock - $0.01 par value; Authorized - 250,000 shares; Issued - 53,247 shares at June 30, 2016 and 53,066 shares at March 31, 2016	532	530
Additional paid-in capital	451,075	445,182
Treasury stock, at cost - 331 shares at June 30, 2016 and 306 shares at March 31, 2016	(6,558)	(5,163)
Accumulated other comprehensive loss, net of tax	(29,349)	(23,525)
Retained earnings	321,781	327,312
Total Stockholders' Equity	737,481	744,336
Total Liabilities and Stockholders' Equity	$ 2,878,440	$ 2,948,791

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Jun. 30, 2016	Mar. 31, 2016
Stockholders' Equity:
Preferred stock, par value (in USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (shares)	5,000,000	5,000,000
Preferred stock, shares issued (shares)	0	0
Preferred stock, shares outstanding (shares)	0	0
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (shares)	250,000,000	250,000,000
Common stock, shares issued (shares)	53,247,000	53,066,000
Treasury stock, (shares)	331,000	306,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Operating Activities
Net (loss) income	$ (5,531)	$ 26,173
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	6,832	5,720
Loss (gain) on sale of assets	55,453	(36)
Deferred income taxes	(9,660)	11,536
Amortization of debt origination costs	2,231	2,138
Stock-based compensation costs	1,940	3,047
Loss on extinguishment of debt	0	451
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	5,151	2,578
Inventories	(4,327)	(211)
Prepaid expenses and other current assets	5,697	(1,522)
Accounts payable	(3,401)	783
Accrued liabilities	(3,634)	(7,136)
Net cash provided by operating activities	50,751	43,521
Investing Activities
Purchases of property and equipment	(895)	(780)
Proceeds from the sale of property and equipment	0	344
Net cash used in investing activities	(895)	(436)
Financing Activities
Term loan repayments	(50,000)	(25,000)
Borrowings under revolving credit agreement	0	15,000
Repayments under revolving credit agreement	0	(35,000)
Payments of debt origination costs	(9)	(4,172)
Proceeds from exercise of stock options	3,405	6,328
Proceeds from restricted stock exercises	0	544
Excess tax benefits from share-based awards	550	1,600
Fair value of shares surrendered as payment of tax withholding	(1,395)	(2,187)
Net cash used in financing activities	(47,449)	(42,887)
Effects of exchange rate changes on cash and cash equivalents	(760)	82
Increase in cash and cash equivalents	1,647	280
Cash and cash equivalents - beginning of period	27,230	21,318
Cash and cash equivalents - end of period	28,877	21,598
Interest paid	18,337	22,444
Income taxes paid	$ 1,357	$ 1,914

Business and Basis of Presentat

Business and Basis of Presentation	3 Months Ended
	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Basis of Presentation	Business and Basis of Presentation Nature of Business Prestige Brands Holdings, Inc. (referred to herein as the “Company” or “we”, which reference shall, unless the context requires otherwise, be deemed to refer to Prestige Brands Holdings, Inc. and all of its direct and indirect 100% owned subsidiaries on a consolidated basis) is engaged in the marketing, sales and distribution of over-the-counter (“OTC”) healthcare and household cleaning products to mass merchandisers, drug stores, supermarkets, and club, convenience, and dollar stores in North America (the United States and Canada) and in Australia and certain other international markets. Prestige Brands Holdings, Inc. is a holding company with no operations and is also the parent guarantor of the senior credit facility and the senior notes described in Note 10 to these Consolidated Financial Statements. Basis of Presentation The unaudited Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. All significant intercompany transactions and balances have been eliminated in these Consolidated Financial Statements. In the opinion of management, these Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented. Our fiscal year ends on March 31 st of each year. References in these Consolidated Financial Statements or related notes to a year (e.g., “2017”) mean our fiscal year ending or ended on March 31 st of that year. Operating results for the three months ended June 30, 2016 are not necessarily indicative of results that may be expected for the fiscal year ending March 31, 2017 . These unaudited Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2016 . Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances and inventory obsolescence, and the recognition of income taxes using an estimated annual effective tax rate. Cash and Cash Equivalents We consider all short-term deposits and investments with original maturities of three months or less to be cash equivalents. Substantially all of our cash is held by a large regional bank with headquarters in California. We do not believe that, as a result of this concentration, we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. The Federal Deposit Insurance Corporation (“FDIC”) and Securities Investor Protection Corporation (“SIPC”) insure these balances up to $250,000 and $500,000, with a $250,000 limit for cash, respectively. Substantially all of the Company's cash balances at June 30, 2016 are uninsured. Accounts Receivable We extend non-interest-bearing trade credit to our customers in the ordinary course of business. We maintain an allowance for doubtful accounts receivable based upon historical collection experience and expected collectability of the accounts receivable. In an effort to reduce credit risk, we (i) have established credit limits for all of our customer relationships, (ii) perform ongoing credit evaluations of customers' financial condition, (iii) monitor the payment history and aging of customers' receivables, and (iv) monitor open orders against an individual customer's outstanding receivable balance. Inventories Inventories are stated at the lower of cost or market value, with cost determined by using the first-in, first-out method. We reduce inventories for diminution of value resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value. Factors utilized in the determination of estimated market value include: (i) current sales data and historical return rates, (ii) estimates of future demand, (iii) competitive pricing pressures, (iv) new product introductions, (v) product expiration dates, and (vi) component and packaging obsolescence. Assets Held for Sale We classify assets or disposal groups to be sold as held for sale in the period in which all of the following criteria are met: (i) management, having the authority to approve the action, commits to a plan to sell the asset or disposal group, (ii) the asset or disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets or disposal groups, (iii) an active program to locate a buyer and other actions required to compete the plan to sell the asset or disposal group have been initiated, (iv) the sale of the asset or disposal group is probable, and transfer of the asset or disposal group is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond our control extend the period of time required to complete the sale of the asset or disposal group beyond one year, (v) the asset or disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value, and (vi) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. We measure an asset or disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held-for-sale criteria are met. Conversely, gains are not recognized on the sale of a long-lived asset or disposal group until the date of sale. We assess the fair value of a long-lived asset or disposal group less any costs to sell each reporting period it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset or disposal group, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale. Upon determining that an asset or disposal group meets the criteria as held for sale, the Company ceases depreciation and reports both long-lived assets and/or the current assets and liabilities of the disposal group, if material, in the line item assets held for sale in our consolidated balance sheet. Refer to Note 3 below for further discussion. Property and Equipment Property and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives: Years Machinery 5 Computer equipment and software 3 Furniture and fixtures 7 Leasehold improvements * *Leasehold improvements are amortized over the lesser of the term of the lease or the estimated useful life of the related asset. Expenditures for maintenance and repairs are charged to expense as incurred. When an asset is sold or otherwise disposed of, we remove the cost and associated accumulated depreciation from the respective accounts and recognize the resulting gain or loss in the Consolidated Statements of Operations and Comprehensive Income. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Goodwill The excess of the purchase price over the fair market value of assets acquired and liabilities assumed in business combinations is classified as goodwill. Goodwill is not amortized, although the carrying value is tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired. Goodwill is tested for impairment at the product group level, which is one level below the operating segment level. Intangible Assets Intangible assets, which are comprised primarily of trademarks, are stated at cost less accumulated amortization. For intangible assets with finite lives, amortization is computed using the straight-line method over estimated useful lives, typically ranging from 10 to 30 years. Indefinite-lived intangible assets are tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired. Intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amounts may exceed their fair values and may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value. Debt Origination Costs We have incurred debt origination costs in connection with the issuance of long-term debt. These costs are amortized over the term of the related debt, using the effective interest method for our term loan facility and the straight-line method for our revolving credit facility. Revenue Recognition Revenues are recognized when the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the selling price is fixed or determinable, (iii) the product has been shipped and the customer takes ownership and assumes the risk of loss, and (iv) collection of the resulting receivable is reasonably assured. We have determined that these criteria are met and the transfer of the risk of loss generally occurs when the product is received by the customer, and, accordingly, we recognize revenue at that time. Provisions are made for estimated discounts related to customer payment terms and estimated product returns at the time of sale based on our historical experience. As is customary in the consumer products industry, we participate in the promotional programs of our customers to enhance the sale of our products. The cost of these promotional programs varies based on the actual number of units sold during a finite period of time. These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. Estimates of the costs of these promotional programs are based on (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel. We recognize the cost of such sales incentives by recording an estimate of such cost as a reduction of revenue, at the later of (a) the date the related revenue is recognized, or (b) the date when a particular sales incentive is offered. At the completion of a promotional program, the estimated amounts are adjusted to actual results. Due to the nature of the consumer products industry, we are required to estimate future product returns. Accordingly, we record an estimate of product returns concurrent with recording sales, which is made after analyzing (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising. Cost of Sales Cost of sales includes product costs, warehousing costs, inbound and outbound shipping costs, and handling and storage costs. Warehousing, shipping and handling and storage costs were $10.5 million for the three months ended June 30, 2016 and $8.7 million for the three months ended June 30, 2015 . Advertising and Promotion Costs Advertising and promotion costs are expensed as incurred. Allowances for new distribution costs associated with products, including slotting fees, are recognized as a reduction of sales. Under these new distribution arrangements, the retailers allow our products to be placed on the stores' shelves in exchange for such fees. Stock-based Compensation We recognize stock-based compensation by measuring the cost of services to be rendered based on the grant-date fair value of the equity award. Compensation expense is recognized over the period a grantee is required to provide service in exchange for the award, generally referred to as the requisite service period. Income Taxes Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized. The Income Taxes topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities. As a result, we have applied such guidance in determining our tax uncertainties. We are subject to taxation in the United States and various state and foreign jurisdictions. We classify penalties and interest related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Operations and Comprehensive Income. Earnings Per Share Basic earnings per share is calculated based on income available to common stockholders and the weighted-average number of shares outstanding during the reporting period. Diluted earnings per share is calculated based on income available to common stockholders and the weighted-average number of common and potential common shares outstanding during the reporting period. Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested restricted stock units, are included in the earnings per share calculation to the extent that they are dilutive. In loss periods, the assumed exercise of in-the-money stock options and restricted stock units has an anti-dilutive effect and therefore, these instruments are excluded from the computation of diluted earnings per share. Recently Issued Accounting Standards In May 2016, the FASB issued Accounting Standards Update ("ASU") 2016-12, Revenue from Contracts with Customers . The amendments do not change the core principle of the guidance in FASB ASC 606. Rather, the amendments in this update affect only certain narrow aspects of FASB ASC 606. The effective date and transition requirements for the amendments in this update are the same as the effective date and transition requirements of ASU 2014-09 described below. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers . The amendments in this update clarify the implementation guidance on identifying performance obligations and licensing in FASB ASC 606. The effective date and transition requirements for the amendments in this update are the same as the effective date and transition requirements of ASU 2014-09 described below. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting . The amendments in this update involve several aspects of accounting for share-based payment transactions, including income tax consequences, classification of awards, and classification on the statement of cash flows. For public business entities, the amendments in this update are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers . The amendments in this update clarify the implementation guidance on principals versus agent considerations in FASB ASC 606. The effective date and transition requirements for the amendments in this update are the same as the effective date and transition requirements of ASU 2014-09 described below. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In February 2016, the FASB issued ASU 2016-02, Leases. The amendments in this update include a new FASB ASC Topic 842, which supersedes Topic 840. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted for all entities as of the beginning of interim or annual reporting periods. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes . The amendments in this update require that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this update may be applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. For public business entities, the amendments in this update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early application is permitted for all entities as of the beginning of interim or annual reporting periods. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In July 2015, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory . The amendments in this update more closely align the measurement of inventory in GAAP with the measurement of inventory in International Financial Reporting Standards, under which an entity should measure inventory at the lower of cost or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. For public business entities, the amendments are effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The adoption of ASU 2015-11 is not expected to have a material impact on our Consolidated Financial Statements. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers - Topic 606 , which supersedes the revenue recognition requirements in FASB ASC 605. The new guidance primarily states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU 2014-09 from annual and interim periods beginning after December 15, 2016 to annual and interim periods beginning after December 15, 2017. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements.

Acquisitions

Acquisitions	3 Months Ended
	Jun. 30, 2016
Business Combinations [Abstract]
Acquisitions	Acquisitions Acquisition of DenTek On February 5, 2016, the Company completed the acquisition of DenTek Holdings, Inc. ("DenTek"), a privately-held marketer and distributor of specialty oral care products. The closing was finalized pursuant to the terms of the merger agreement, announced November 23, 2015, under which Prestige agreed to acquire DenTek from its stockholders, including TSG Consumer Partners, for a purchase price of $228.3 million . The acquisition expands Prestige's portfolio of brands, strengthens its existing oral care platform and increases its geographic reach in parts of Europe. The Company financed the transaction with a combination of available cash on hand, available cash from its Asset Based Loan revolver, and financing of an additional unsecured bridge loan. The DenTek brands are primarily included in the Company's North American and International OTC Healthcare segments. The DenTek acquisition was accounted for in accordance with the Business Combinations topic of the FASB ASC 805, which requires that the total cost of an acquisition be allocated to the tangible and intangible assets acquired and liabilities assumed based upon their respective fair values at the date of acquisition. We prepared an analysis of the fair values of the assets acquired and liabilities assumed as of the date of acquisition. The following table summarizes our preliminary allocation of the assets acquired and liabilities assumed as of the February 5, 2016 acquisition date. (In thousands) February 5, 2016 Cash acquired $ 1,359 Accounts receivable 9,187 Inventories 14,304 Deferred income taxes 3,303 Prepaids and other current assets 6,728 Property, plant and equipment, net 3,555 Goodwill 76,529 Intangible assets, net 206,700 Total assets acquired 321,665 Accounts payable 3,261 Accrued expenses 16,488 Deferred income tax liabilities - long term 73,573 Total liabilities assumed 93,322 Total purchase price $ 228,343 Based on this preliminary analysis, we allocated $179.8 million to non-amortizable intangible assets and $26.9 million to amortizable intangible assets. We are amortizing the purchased amortizable intangible assets on a straight-line basis over an estimated weighted average useful life of 18.5 years. The weighted average remaining life for amortizable intangible assets at June 30, 2016 was 18.2 years. We also recorded goodwill of $76.5 million based on the amount by which the purchase price exceeded the fair value of the net assets acquired. Goodwill is not deductible for income tax purposes. The pro forma effect of this acquisition on revenues and earnings was not material.

Assets Held for Sale

Assets Held for Sale	3 Months Ended
	Jun. 30, 2016
Discontinued Operations and Disposal Groups [Abstract]
Assets Held for Sale	Assets Held for Sale Assets Held for Sale Late in the first quarter of fiscal 2017, the Company was approached and discussed the potential to sell certain assets. Prior to these discussions, the Company did not contemplate any divestitures, and the Company did not commit to any course of action to divest any of the assets until entering into an agreement on June 29, 2016, to sell Pediacare , New Skin and Fiber Choice. The carrying value of Pediacare , New Skin and Fiber Choice at June 30, 2016 (including inventory) was $ 24.1 million, $ 30.6 million, and $ 11.4 million, respectively. The purchase price for all three brands combined was $40.0 million plus inventory and included an obligation of the Company to perform certain services on behalf of the buyer for a period of up to six months (the "Transitional Services Agreement" or "TSA") and an option to the buyer to purchase Dermoplast at a specified earnings multiple as defined in the agreement. The Pediacare , New Skin and Fiber Choice brands were reported under the Cough & Cold, Dermatologicals and Gastrointestinal product groups, respectively, and all these brands were reported under the North American OTC Healthcare segment. This transaction met the criteria as held for sale, and the related assets were measured at the lower of the carrying value or fair value less any costs to sell based on the agreed-upon sales price. As a result, as of June 30, 2016, we recorded the held for sale assets at their estimated fair value and recorded a pre-tax loss on sale of assets of $ 55.5 million . This transaction closed in July 2016 and as of June 30, 2016, the total assets held for sale, net of the loss recognized, related to Pediacare , New Skin and Fiber Choice were: (In thousands) June 30, Components of assets held for sale: Inventory $ 2,420 Intangible assets, net 36,405 Goodwill 2,920 Assets held for sale $ 41,745 Refer to Note 21 below for further information. Additionally, we determined that this transaction did not meet the criteria to be classified as discontinued operations under FASB ASC 205.

Accounts Receivable

Accounts Receivable	3 Months Ended
	Jun. 30, 2016
Receivables [Abstract]
Accounts Receivable	Accounts Receivable Accounts receivable consist of the following: (In thousands) June 30, March 31, Components of Accounts Receivable Trade accounts receivable $ 98,513 $ 105,592 Other receivables 1,046 1,261 99,559 106,853 Less allowances for discounts, returns and uncollectible accounts (11,122 ) (11,606 ) Accounts receivable, net $ 88,437 $ 95,247

Inventories

Inventories	3 Months Ended
	Jun. 30, 2016
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories consist of the following: (In thousands) June 30, March 31, Components of Inventories Packaging and raw materials $ 7,442 $ 7,563 Finished goods 85,425 83,700 Inventories $ 92,867 $ 91,263 Inventories are carried and depicted above at the lower of cost or market value, which includes a reduction in inventory values of $5.2 million and $4.8 million at June 30, 2016 and March 31, 2016 , respectively, related to obsolete and slow-moving inventory.

Property and Equipment

Property and Equipment	3 Months Ended
	Jun. 30, 2016
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment consist of the following: (In thousands) June 30, March 31, Components of Property and Equipment Machinery $ 8,444 $ 7,734 Computer equipment 13,154 12,793 Furniture and fixtures 2,444 2,445 Leasehold improvements 7,384 7,389 31,426 30,361 Accumulated depreciation (16,346 ) (14,821 ) Property and equipment, net $ 15,080 $ 15,540 We recorded depreciation expense of $1.5 million and $1.3 million for the three months ended June 30, 2016 and 2015, respectively.

Goodwill

Goodwill	3 Months Ended
	Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill A reconciliation of the activity affecting goodwill by operating segment is as follows: (In thousands) North American OTC Healthcare International OTC Healthcare Household Cleaning Consolidated Balance — March 31, 2016 $ 330,615 $ 22,776 $ 6,800 $ 360,191 Reclassified to assets held for sale (2,920 ) — — (2,920 ) Effects of foreign currency exchange rates — (746 ) — (746 ) Balance — June 30, 2016 $ 327,695 $ 22,030 $ 6,800 $ 356,525 As discussed in Note 2, on February 5, 2016, we completed the acquisition of DenTek. In connection with this acquisition, we recorded goodwill of $76.5 million based on the amount by which the purchase price exceeded the fair value of net assets acquired. Under accounting guidelines, goodwill is not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below the carrying amount. On an annual basis during the fourth quarter of each fiscal year, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of the values assigned to goodwill and tests for impairment. At February 29, 2016 , during our annual test for goodwill impairment, there were no indicators of impairment under the analysis. Accordingly, no impairment charge was recorded in fiscal 2016. We utilize the discounted cash flow method to estimate the fair value of our reporting units as part of the goodwill impairment test. We also considered our market capitalization at February 29, 2016 , which was the date of our annual review, as compared to the aggregate fair values of our reporting units, to assess the reasonableness of our estimates pursuant to the discounted cash flow methodology. The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties. Consequently, changing rates of interest and inflation, declining sales or margins, increases in competition, changing consumer preferences, technical advances, or reductions in advertising and promotion may require an impairment charge to be recorded in the future. On June 29, 2016, we entered into an agreement to sell Pediacare , New Skin and Fiber Choice . This transaction (see Note 3 above for further details) met the criteria as held for sale, and the related assets were measured at the lower of carrying value or fair value less cost to sell. As a result, the allocable portion of goodwill related to these businesses were reclassed and included in assets held for sale. As of June 30, 2016, no events have occurred that would indicate potential impairment of goodwill.

Intangible Assets

Intangible Assets	3 Months Ended
	Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets A reconciliation of the activity affecting intangible assets is as follows: (In thousands) Indefinite Lived Trademarks Finite Lived Totals Gross Carrying Amounts Balance — March 31, 2016 $ 2,020,046 $ 417,880 $ 2,437,926 Reclassified to assets held for sale (37,207 ) (60,103 ) (97,310 ) Effects of foreign currency exchange rates (2,545 ) (107 ) (2,652 ) Balance — June 30, 2016 1,980,294 357,670 2,337,964 Accumulated Amortization Balance — March 31, 2016 — 115,203 115,203 Reclassified to assets held for sale — (6,102 ) (6,102 ) Additions — 5,313 5,313 Effects of foreign currency exchange rates — (9 ) (9 ) Balance — June 30, 2016 — 114,405 114,405 Intangible assets, net - June 30, 2016 $ 1,980,294 $ 243,265 $ 2,223,559 Intangible Assets, net by Reportable Segment: North American OTC Healthcare $ 1,786,666 $ 219,570 $ 2,006,236 International OTC Healthcare 83,356 1,453 84,809 Household Cleaning 110,272 22,242 132,514 Intangible assets, net - June 30, 2016 $ 1,980,294 $ 243,265 $ 2,223,559 On June 29, 2016, we entered into an agreement to sell Pediacare , New Skin and Fiber Choice . This transaction (see Note 3 above for further details) met the criteria as held for sale, and the related assets were measured at the lower of the carrying value or fair value less cost to sell based on the agreed-upon sales price. As a result, as of June 30, 2016, we recorded the held for sale assets at their estimated fair value and recorded a pre-tax loss of $ 55.5 million and reclassified $37.2 million and $54.0 million of indefinite and finite lived trademarks, respectively, to assets held for sale. As discussed in Note 2, on February 5, 2016, we completed the acquisition of DenTek. In connection with this acquisition, we allocated $206.7 million to intangible assets based on our analysis. Under accounting guidelines, indefinite-lived assets are not amortized, but must be tested for impairment annually, or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the asset below the carrying amount. Additionally, at each reporting period, an evaluation must be made to determine whether events and circumstances continue to support an indefinite useful life. Intangible assets with finite lives are amortized over their respective estimated useful lives and are also tested for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable and exceeds its fair value. On an annual basis during the fourth fiscal quarter, or more frequently if conditions indicate that the carrying value of the asset may not be recoverable, management performs a review of both the values and, if applicable, useful lives assigned to intangible assets and tests for impairment. We utilize the excess earnings method to estimate the fair value of our individual indefinite-lived intangible assets. We also considered our market capitalization at February 29, 2016 , which was the date of our annual review. The estimates and assumptions made in assessing the fair value of our reporting units and the valuation of the underlying assets and liabilities are inherently subject to significant uncertainties. Consequently, changing rates of interest and inflation, declining sales or margins, increases in competition, changing consumer preferences, technical advances, or reductions in advertising and promotion may require an impairment charge to be recorded in the future. The weighted average remaining life for finite-lived intangible assets at June 30, 2016 was approximately 13.4 years, and the amortization expense for the three months ended June 30, 2016 was $5.3 million . At June 30, 2016 , finite-lived intangible assets are being amortized over a period of 10 to 30 years, and the associated amortization expense is expected to be as follows: (In thousands) Year Ending March 31, Amount 2017 (Remaining nine months ending March 31, 2017) $ 13,654 2018 18,049 2019 18,049 2020 18,049 2021 17,626 Thereafter 157,838 $ 243,265

Other Accrued Liabilities

Other Accrued Liabilities	3 Months Ended
	Jun. 30, 2016
Payables and Accruals [Abstract]
Other Accrued Liabilities	Other Accrued Liabilities Other accrued liabilities consist of the following: (In thousands) June 30, March 31, Accrued marketing costs $ 29,410 $ 26,373 Accrued compensation costs 4,275 9,574 Accrued broker commissions 564 1,497 Income taxes payable 3,282 3,675 Accrued professional fees 2,226 1,787 Deferred rent 747 836 Accrued production costs 3,413 3,324 Accrued lease termination costs 417 448 Income tax related payable 6,354 6,354 Other accrued liabilities 5,225 5,856 $ 55,913 $ 59,724

Long-Term Debt

Long-Term Debt	3 Months Ended
	Jun. 30, 2016
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt 2012 Term Loan and 2012 ABL Revolver: On January 31, 2012, Prestige Brands, Inc. (the "Borrower") entered into a new senior secured credit facility, which consists of (i) a $660.0 million term loan facility (the “2012 Term Loan”) with a 7 -year maturity and (ii) a $50.0 million asset-based revolving credit facility (the “2012 ABL Revolver”) with a 5 -year maturity. In subsequent years, we have utilized portions of our accordion feature to increase the amount of our borrowing capacity under the 2012 ABL Revolver by $85.0 million to $135.0 million and reduced our borrowing rate on the 2012 ABL Revolver by 0.25% (discussed below). The 2012 Term Loan was issued with an original issue discount of 1.5% of the principal amount thereof, resulting in net proceeds to the Borrower of $650.1 million . In connection with these loan facilities, we incurred $20.6 million of costs, which were capitalized as deferred financing costs and are being amortized over the terms of the facilities. The 2012 Term Loan is unconditionally guaranteed by Prestige Brands Holdings, Inc. and certain of its domestic 100% owned subsidiaries, other than the Borrower. Each of these guarantees is joint and several. There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries or to make payments to the Borrower or the Company. On February 21, 2013, we entered into Amendment No. 1 ("Term Loan Amendment No. 1") to the 2012 Term Loan. Term Loan Amendment No. 1 provided for the refinancing of all of the Borrower's existing Term B Loans with new Term B-1 Loans (the "Term B-1 Loans"). The interest rate on the Term B-1 Loans under Term Loan Amendment No. 1 was based, at the Borrower's option, on a LIBOR rate plus a margin of 2.75% per annum, with a LIBOR floor of 1.00% , or an alternate base rate, with a floor of 2.00% , plus a margin. The new Term B-1 Loans would have matured on the same date as the Term B Loans' original maturity date. In addition, Term Loan Amendment No. 1 provided the Borrower with certain additional capacity to prepay subordinated debt, the 8.125% senior notes due in 2020 and certain other unsecured indebtedness permitted to be incurred under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver. In connection with Term Loan Amendment No. 1, during the fourth quarter ended March 31, 2013, we recognized a $1.4 million loss on the extinguishment of debt. On September 3, 2014, we entered into Amendment No. 2 ("Term Loan Amendment No. 2") to the 2012 Term Loan. Term Loan Amendment No. 2 provided for (i) the creation of a new class of Term B-2 Loans under the 2012 Term Loan (the "Term B-2 Loans") in an aggregate principal amount of $720.0 million , (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility and financial maintenance covenant relief, and (iii) an interest rate on (x) the Term B-1 Loans that was based, at our option, on a LIBOR rate plus a margin of 3.125% per annum, with a LIBOR floor of 1.00% , or an alternate base rate, with a floor of 2.00% , plus a margin, and (y) the Term B-2 Loans that was based, at our option, on a LIBOR rate plus a margin of 3.50% per annum, with a LIBOR floor of 1.00% , or an alternate base rate, with a floor of 2.00% , plus a margin (with a margin step-down to 3.25% per annum, based upon achievement of a specified secured net leverage ratio). Also, on September 3, 2014, the Borrower entered into Amendment No. 3 ("ABL Amendment No. 3") to the 2012 ABL Revolver. ABL Amendment No. 3 provides for (i) a $40.0 million increase in revolving commitments under the 2012 ABL Revolver and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan and 2012 ABL Revolver, including additional investment, restricted payment and debt incurrence flexibility. Borrowings under the 2012 ABL Revolver, as amended, bear interest at a rate per annum equal to an applicable margin, plus, at the Borrower's option, either (i) a base rate determined by reference to the highest of (a) the Federal Funds rate plus 0.50% , (b) the prime rate of Citibank, N.A., and (c) the LIBOR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month, adjusted for certain additional costs, plus 1.00% or (ii) a LIBOR rate determined by reference to the costs of funds for U.S. dollar deposits for the interest period relevant to such borrowing, adjusted for certain additional costs. The applicable margin for borrowings under the 2012 ABL Revolver may be increased to 2.00% or 2.25% for LIBOR borrowings and 1.00% or 1.25% for base-rate borrowings, depending on average excess availability under the 2012 ABL Revolver during the prior fiscal quarter. In addition to paying interest on outstanding principal under the 2012 ABL Revolver, we are required to pay a commitment fee to the lenders under the 2012 ABL Revolver in respect of the unutilized commitments thereunder. The initial commitment fee rate is 0.50% per annum. The commitment fee rate will be reduced to 0.375% per annum at any time when the average daily unused commitments for the prior quarter is less than a percentage of total commitments by an amount set forth in the credit agreement covering the 2012 ABL Revolver. We may voluntarily repay outstanding loans under the 2012 ABL Revolver at any time without a premium or penalty. On May 8, 2015, we entered into Amendment No. 3 ("Term Loan Amendment No. 3") to the 2012 Term Loan. Term Loan Amendment No. 3 provides for (i) the creation of a new class of Term B-3 Loans under the 2012 Term Loan (the "Term B-3 Loans") in an aggregate principal amount of $852.5 million , which combined the outstanding balances of the Term B-1 Loans of $207.5 million and the Term B-2 Loans of $645.0 million , and (ii) increased flexibility under the credit agreement governing the 2012 Term Loan, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief. The maturity date of the Term B-3 Loans remains the same as the Term B-2 Loans' original maturity date of September 3, 2021. The 2012 Term Loan, as amended, bears interest at a rate per annum equal to an applicable margin plus, at our option, either (i) a base rate determined by reference to the highest of (a) the Federal Funds rate plus 0.50% , (b) the prime rate of Citibank, N.A., (c) the LIBOR rate determined by reference to the cost of funds for U.S. dollar deposits for an interest period of one month, adjusted for certain additional costs, plus 1.00% and (d) a floor of 1.75% or (ii) a LIBOR rate determined by reference to the costs of funds for U.S. dollar deposits for the interest period relevant to such borrowing, adjusted for certain additional costs, with a floor of 0.75% . For the three months ended June 30, 2016, the average interest rate on the 2012 Term Loan was 4.7% . Under the 2012 Term Loan, the Borrower was originally required to make quarterly payments each equal to 0.25% of the original principal amount of the 2012 Term Loan, with the balance expected to be due on the seventh anniversary of the closing date. However, since the Borrower has previously made significant optional payments that exceeded all of our required quarterly payments, the Borrower will not be required to make another payment until the maturity date of March 31, 2019. On June 9, 2015, we entered into Amendment No. 4 (“ABL Amendment No. 4”) to the 2012 ABL Revolver. ABL Amendment No. 4 provides for (i) a $35.0 million increase in the accordion feature under the 2012 ABL Revolver and (ii) increased flexibility under the credit agreement governing the 2012 ABL Revolver, including additional investment, restricted payment, and debt incurrence flexibility and financial maintenance covenant relief and (iii) extended the maturity date of the 2012 ABL Revolver to June 9, 2020, which is five years from the effective date. We may voluntarily repay outstanding loans under the 2012 ABL Revolver at any time without a premium or penalty. For the three months ended June 30, 2016, the average interest rate on the amounts borrowed under the 2012 ABL Revolver was 2.2% . In connection with the DenTek acquisition on February 5, 2016, we entered into Amendment No. 5 (“ABL Amendment No. 5”) to the 2012 ABL Revolver. ABL Amendment No. 5 temporarily suspended certain financial and related reporting covenants in the 2012 ABL Revolver until the earliest of (i) the date that is 60 calendar days following February 4, 2016, (ii) the date upon which certain of DenTek’s assets are included in the Company’s borrowing base under the 2012 ABL Revolver and (iii) the date upon which the Company receives net proceeds from an offering of debt securities. 2013 Senior Notes: On December 17, 2013, the Borrower issued $400.0 million of senior unsecured notes, with an interest rate of 5.375% and a maturity date of December 15, 2021 (the "2013 Senior Notes"). The Borrower may redeem some or all of the 2013 Senior Notes at redemption prices set forth in the indenture governing the 2013 Senior Notes. The 2013 Senior Notes are guaranteed by Prestige Brands Holdings, Inc. and certain of its 100% domestic owned subsidiaries, other than the Borrower. Each of these guarantees is joint and several. There are no significant restrictions on the ability of any of the guarantors to obtain funds from their subsidiaries or to make payments to the Borrower or the Company. In connection with the 2013 Senior Notes offering, we incurred $7.2 million of costs, which were capitalized as deferred financing costs and are being amortized over the term of the 2013 Senior Notes. 2016 Senior Notes: On February 19, 2016, the Borrower completed the sale of $350.0 million aggregate principal amount of 6.375% senior notes due 2024 (the “2016 Senior Notes”), pursuant to a purchase agreement, dated February 16, 2016, among the Borrower, the guarantors party thereto (the “Guarantors”) and the initial purchasers party thereto. The 2016 Senior Notes are guaranteed by Prestige Brands Holdings, Inc. and certain of its domestic 100% owned subsidiaries, other than the Borrower. Each of these guarantees is joint and several. There are no significant restrictions on the ability of any of the Guarantors to obtain funds from their subsidiaries or to make payments to the Borrower or the Company. In connection with the 2016 Senior Notes offering, we incurred $5.5 million of costs, which were capitalized as deferred financing costs and are being amortized over the term of the 2016 Senior Notes. The 2016 Senior Notes were issued pursuant to an indenture, dated February 19, 2016 (the “Indenture”). The Indenture provides, among other things, that interest will be payable on the 2016 Senior Notes on March 1 and September 1 of each year, beginning on September 1, 2016, until their maturity date of March 1, 2024. The 2016 Senior Notes are senior unsecured obligations of the Borrower. Redemptions and Restrictions: At any time prior to December 15, 2016, we have the option to redeem the 2013 Senior Notes in whole or in part at a redemption price equal to 100% of the principal amount of notes redeemed, plus an applicable "make-whole premium" calculated as set forth in the indenture governing the 2013 Senior Notes, together with accrued and unpaid interest, if any, to the date of redemption. On or after December 15, 2016, we have the option to redeem some or all of the 2013 Senior Notes at redemption prices set forth in the indenture governing the 2013 Senior Notes. In addition, at any time prior to December 15, 2016, we have to the option to redeem up to 35% of the aggregate principal amount of the 2013 Senior Notes at a redemption price equal to 105.375% of the principal amount thereof, plus accrued and unpaid interest, if any, to the redemption date, with the net cash proceeds of certain equity offerings, provided that certain conditions are met. Subject to certain limitations, in the event of a change of control, as defined in the indenture governing the 2013 Senior Notes, the Borrower will be required to make an offer to purchase the 2013 Senior Notes at a price equal to 101% of the aggregate principal amount of the 2013 Senior Notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase. The Borrower has the option to redeem all or a portion of the 2016 Senior Notes at any time on or after March 1, 2019 at the redemption prices set forth in the Indenture, plus accrued and unpaid interest, if any. The Borrower may also redeem all or any portion of the 2016 Senior Notes at any time prior to March 1, 2019, at a price equal to 100% of the aggregate principal amount of the notes redeemed, plus an applicable "make-whole premium" calculated as set forth in the Indenture, and accrued and unpaid interest, if any, to the date of redemption. In addition, before March 1, 2019, the Borrower may redeem up to 40% of the aggregate principal amount of the 2016 Senior Notes with the net proceeds of certain equity offerings at the redemption price set forth in the Indenture, provided that certain conditions are met. Subject to certain limitations, in the event of a change of control, as defined in the Indenture, the Borrower will be required to make an offer to purchase the 2016 Senior Notes at a price equal to 101% of the aggregate principal amount of the notes repurchased, plus accrued and unpaid interest, if any, to the date of repurchase. The indentures governing the 2013 Senior Notes and the 2016 Senior Notes contain provisions that restrict us from undertaking specified corporate actions, such as asset dispositions, acquisitions, dividend payments, repurchases of common shares outstanding, changes of control, incurrences of indebtedness, issuance of equity, creation of liens, making of loans and transactions with affiliates. Additionally, the credit agreement with respect to the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2013 Senior Notes and the 2016 Senior Notes contain cross-default provisions, whereby a default pursuant to the terms and conditions of certain indebtedness will cause a default on the remaining indebtedness under the credit agreement governing the 2012 Term Loan and the 2012 ABL Revolver and the indentures governing the 2013 Senior Notes and the 2016 Senior Notes. At March 31, 2016, we were in compliance with the covenants under our long-term indebtedness. At June 30, 2016, we had an aggregate of $1.2 million of unamortized debt costs related to the 2012 ABL Revolver included in other long-term assets, and $25.1 million of unamortized debt costs included in long-term debt costs, the total of which is comprised of $5.2 million related to the 2013 Senior Notes, $5.3 million related to the 2016 Senior Notes, and $14.6 million related to the 2012 Term Loan. At March 31, 2016 we had an aggregate of $1.3 million of unamortized debt costs related to the 2012 ABL Revolver included in other long-term assets, and $27.2 million of unamortized debts costs included in long-term debt costs, the total of which is comprised of $5.4 million related to the 2013 Senior Notes, $5.4 million related to the 2016 Senior Notes, and $16.4 million related to the 2012 Term Loan. At June 30, 2016, we had $85.0 million outstanding on the 2012 ABL Revolver and a borrowing capacity of $38.6 million . Long-term debt consists of the following, as of the dates indicated: (In thousands, except percentages) June 30, March 31, 2016 Senior Notes bearing interest at 6.375%, with interest payable on March 1 and September 1 of each year. The 2016 Senior Notes mature on March 1, 2024. $ 350,000 $ 350,000 2013 Senior Notes bearing interest at 5.375%, with interest payable on June 15 and December 15 of each year. The 2013 Senior Notes mature on December 15, 2021. 400,000 400,000 2012 Term B-3 Loans bearing interest at the Borrower's option at either a base rate with a floor of 1.75% plus applicable margin or LIBOR with a floor of 0.75% plus applicable margin, due on September 3, 2021. 767,500 817,500 2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin. Any unpaid balance is due on June 9, 2020. 85,000 85,000 Total long-term debt (including current portion) 1,602,500 1,652,500 Current portion of long-term debt — — Long-term debt 1,602,500 1,652,500 Less: unamortized debt costs (25,086 ) (27,191 ) Long-term debt, net $ 1,577,414 $ 1,625,309 At June 30, 2016, aggregate future principal payments required in accordance with the terms of the 2012 Term Loan, 2012 ABL Revolver and the indentures governing the 2016 Senior Notes and the 2013 Senior Notes are as follows: (In thousands) Year Ending March 31, Amount 2017 (remaining nine months ending March 31, 2017) $ — 2018 — 2019 — 2020 — 2021 85,000 Thereafter 1,517,500 $ 1,602,500

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Jun. 30, 2016
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements For certain of our financial instruments, including cash, accounts receivable, accounts payable and other current liabilities, the carrying amounts approximate their respective fair values due to the relatively short maturity of these amounts. The Fair Value Measurements and Disclosures topic of the FASB ASC 820 requires fair value to be determined based on the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market assuming an orderly transaction between market participants. The Fair Value Measurements and Disclosures topic established market (observable inputs) as the preferred source of fair value, to be followed by the Company's assumptions of fair value based on hypothetical transactions (unobservable inputs) in the absence of observable market inputs. Based upon the above, the following fair value hierarchy was created: Level 1 - Quoted market prices for identical instruments in active markets; Level 2 - Quoted prices for similar instruments in active markets, as well as quoted prices for identical or similar instruments in markets that are not considered active; and Level 3 - Unobservable inputs developed by the Company using estimates and assumptions reflective of those that would be utilized by a market participant. The market values have been determined based on market values for similar instruments adjusted for certain factors. As such, the 2016 Senior Notes, the 2013 Senior Notes, the Term B-3 loans, and the 2012 ABL Revolver are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these borrowings at June 30, 2016 and March 31, 2016). June 30, 2016 March 31, 2016 (In thousands) Carrying Value Fair Value Carrying Value Fair Value 2016 Senior Notes $ 350,000 $ 359,625 $ 350,000 $ 363,125 2013 Senior Notes 400,000 404,000 400,000 408,000 Term B-3 Loans 767,500 766,541 817,500 818,522 2012 ABL Revolver 85,000 85,000 85,000 85,000 At June 30, 2016 and March 31, 2016, we did not have any assets or liabilities measured in Level 1 or 3. Nonrecurring Fair Value Measurements As of June 30, 2016, and in addition to the recurring fair value measurements disclosed above, we recorded the long-lived held for sale assets (discussed in Note 3 above) at fair value, using level 3 inputs, and recorded a pre-tax loss on sale of assets of $ 55.5 million ( $35.5 million after-tax).

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Jun. 30, 2016
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Stockholders' Equity The Company is authorized to issue 250.0 million shares of common stock, $0.01 par value per share, and 5.0 million shares of preferred stock, $0.01 par value per share. The Board of Directors may direct the issuance of the undesignated preferred stock in one or more series and determine preferences, privileges and restrictions thereof. Each share of common stock has the right to one vote on all matters submitted to a vote of stockholders. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Board of Directors, subject to prior rights of holders of all classes of outstanding stock having priority rights as to dividends. No dividends have been declared or paid on the Company's common stock through June 30, 2016 . During the three months ended June 30, 2016 and 2015, we repurchased 24,988 shares and 39,429 shares, respectively, of restricted common stock from our employees pursuant to the provisions of various employee restricted stock awards. The repurchases for the three months ended June 30, 2016 and 2015 were at an average price of $55.82 and $41.66 , respectively. All of the repurchased shares have been recorded as treasury stock.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	Jun. 30, 2016
Stockholders' Equity Note [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The table below presents accumulated other comprehensive loss (“AOCI”), which affects equity and results from recognized transactions and other economic events, other than transactions with owners in their capacity as owners. AOCI consisted of the following at June 30, 2016 and March 31, 2016 : June 30, March 31, (In thousands) 2016 2016 Components of Accumulated Other Comprehensive Loss Cumulative translation adjustment $ (29,349 ) $ (23,525 ) Accumulated other comprehensive loss, net of tax $ (29,349 ) $ (23,525 )

Earnings Per Share

Earnings Per Share	3 Months Ended
	Jun. 30, 2016
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic earnings per share is computed based on the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share is computed based on the weighted-average number of shares of common stock outstanding plus the effect of potentially dilutive common shares outstanding during the period using the treasury stock method, which includes stock options and restricted stock units. In loss periods, the assumed exercise of in-the-money stock options and restricted stock units has an anti-dilutive effect and therefore, these instruments are excluded from the computation of diluted earnings per share. The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended June 30, (In thousands, except per share data) 2016 2015 Numerator Net (loss) income $ (5,531 ) $ 26,173 Denominator Denominator for basic earnings per share — weighted average shares outstanding 52,881 52,548 Dilutive effect of unvested restricted stock units and options issued to employees and directors — 410 Denominator for diluted earnings per share 52,881 52,958 Earnings per Common Share: Basic net (loss) earnings per share $ (0.10 ) $ 0.50 Diluted net (loss) earnings per share $ (0.10 ) $ 0.49 For the three months ended June 30, 2016 and 2015 there were 0.7 million and 0.2 million shares, respectively, attributable to outstanding stock-based awards that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive.

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Compensation	Share-Based Compensation In connection with our initial public offering, the Board of Directors adopted the 2005 Long-Term Equity Incentive Plan (the “Plan”), which provides for grants of up to a maximum of 5.0 million shares of restricted stock, stock options, restricted stock units and other equity-based awards. In June 2014, the Board of Directors approved, and in July 2014, the stockholders ratified, an increase of an additional 1.8 million shares of our common stock for issuance under the Plan, increased the maximum number of shares subject to stock options that may be awarded to any one participant under the Plan during any 12-month period from 1.0 million to 2.5 million shares, and extended the term of the Plan by ten years to February 2025. Directors, officers and other employees of the Company and its subsidiaries, as well as others performing services for the Company, are eligible for grants under the Plan. During the three months ended June 30, 2016 and 2015, pre-tax share-based compensation costs charged against income were $1.9 million and $3.0 million , respectively, and the related income tax benefit recognized was $0.7 million and $1.1 million , respectively. On May 9, 2016, the Compensation Committee of our Board of Directors granted 49,064 shares of restricted common stock units and stock options to acquire 224,843 shares of our common stock to certain executive officers and employees under the Plan. All of the shares of restricted common stock units vest in their entirety on the three -year anniversary of the date of grant. Upon vesting, the units will be settled in shares of our common stock. The stock options will vest 33.3% per year over three years and are exercisable for up to ten years from the date of grant. These stock options were granted at an exercise price of $57.18 per share, which is equal to the closing price for our common stock on the date of the grant. Termination of employment prior to vesting will result in forfeiture of the unvested restricted common stock units and the unvested stock options. Vested stock options will remain exercisable by the employee after termination, subject to the terms of the Plan. Restricted Shares Restricted shares granted to employees under the Plan generally vest in three to five years, primarily upon the attainment of certain time vesting thresholds, and may also be contingent on the attainment of certain performance goals of the Company, including revenue and earnings before income taxes, depreciation and amortization targets. The restricted stock unit awards provide for accelerated vesting if there is a change of control, as defined in the Plan. The restricted stock units granted to employees generally vest in their entirety on the three -year anniversary of the date of the grant. Termination of employment prior to vesting will result in forfeiture of the restricted stock units, unless otherwise accelerated by the Compensation Committee. The restricted stock units granted to directors vest in their entirety one year after the date of grant so long as the membership on the Board of Directors continues through the vesting date, with the settlement in common stock to occur on the earliest of the director's death, disability or six-month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability. Upon vesting, the units will be settled in shares of our common stock. Each of our six independent members of the Board of Directors received a grant of 2,075 restricted stock units on August 4, 2015 under the Plan. Additionally, on May 26, 2016 and May 11, 2015, the Compensation Committee granted 346 restricted stock units and 362 restricted stock units, respectively, to newly appointed Board members. The restricted stock units vest on the one year anniversary of the date of grant and will be settled by delivery to the director of one share of common stock of the Company for each vested restricted stock unit promptly following the earliest of the director's (i) death, (ii) disability or (iii) the six -month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability. The fair value of the restricted stock units is determined using the closing price of our common stock on the date of the grant. The weighted-average grant-date fair value during the three months ended June 30, 2016 and 2015 was $57.16 and $41.85 , respectively. A summary of the Company's restricted stock units granted under the Plan is presented below: Restricted Stock Units Shares (in thousands) Weighted- Average Grant-Date Fair Value Three months ended June 30, 2015 Vested and nonvested at March 31, 2015 362.3 $ 22.74 Granted 243.8 41.85 Vested and issued (138.9 ) 19.35 Forfeited (1.4 ) 33.50 Vested and nonvested at June 30, 2015 465.8 33.72 Vested at June 30, 2015 76.6 11.62 Three months ended June 30, 2016 Vested and nonvested at March 31, 2016 467.8 $ 35.22 Granted 49.4 57.16 Vested and issued (75.6 ) 31.36 Forfeited (76.2 ) 39.93 Vested and nonvested at June 30, 2016 365.4 38.00 Vested at June 30, 2016 70.2 14.89 Options The Plan provides that the exercise price of options granted shall be no less than the fair market value of the Company's common stock on the date the options are granted. Options granted have a term of no greater than ten years from the date of grant and vest in accordance with a schedule determined at the time the option is granted, generally three to five years. The option awards provide for accelerated vesting in the event of a change in control, as defined in the Plan. Termination of employment prior to vesting will result in forfeiture of the unvested stock options. Vested stock options will remain exercisable by the employee after termination of employment, subject to the terms in the Plan. The fair value of each option award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions noted in the table below. Expected volatilities are based on the historical volatility of our common stock and other factors, including the historical volatilities of comparable companies. We use appropriate historical data, as well as current data, to estimate option exercise and employee termination behaviors. Employees that are expected to exhibit similar exercise or termination behaviors are grouped together for the purposes of valuation. The expected terms of the options granted are derived from our historical experience, management's estimates, and consideration of information derived from the public filings of companies similar to us, and represent the period of time that options granted are expected to be outstanding. The risk-free rate represents the yield on U.S. Treasury bonds with a maturity equal to the expected term of the granted options. The weighted-average grant-date fair values of the options granted during the three months ended June 30, 2016 and 2015 were $22.26 and $16.95 , respectively. Three months ended June 30, 2016 2015 Expected volatility 37.8 % 40.2 % Expected dividends $ — $ — Expected term in years 6.0 6.0 Risk-free rate 1.7 % 1.7 % A summary of option activity under the Plan is as follows: Options Shares (in thousands) Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in thousands) Three months ended June 30, 2015 Outstanding at March 31, 2015 871.2 $ 23.40 Granted 186.3 41.44 Exercised (330.4 ) 19.15 Forfeited or expired (0.9 ) 33.50 Outstanding at June 30, 2015 726.2 29.95 8.3 $ 11,830 Exercisable at June 30, 2015 322.5 21.54 7.2 7,966 Three months ended June 30, 2016 Outstanding at March 31, 2016 727.7 $ 30.70 Granted 224.8 57.18 Exercised (105.7 ) 32.20 Forfeited or expired (45.5 ) 37.34 Outstanding at June 30, 2016 801.3 37.55 8.0 $ 14,700 Exercisable at June 30, 2016 386.4 25.20 6.7 11,669 The aggregate intrinsic value of options exercised in the three months ended June 30, 2016 was $2.3 million . At June 30, 2016 , there were $13.8 million of unrecognized compensation costs related to nonvested share-based compensation arrangements under the Plan, based on management's estimate of the shares that will ultimately vest. We expect to recognize such costs over a weighted-average period of 1.1 years. The total fair value of options and restricted stock units vested during the three months ended June 30, 2016 and 2015 was $7.0 million and $6.2 million , respectively. For the three months ended June 30, 2016 and 2015, cash received from the exercise of stock options was $3.4 million and $6.3 million , respectively, and we realized $0.7 million and $1.0 million , respectively, in tax benefits from the tax deductions resulting from these option exercises. At June 30, 2016 , there were 2.4 million shares available for issuance under the Plan.

Income Taxes

Income Taxes	3 Months Ended
	Jun. 30, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income taxes are recorded in our quarterly financial statements based on our estimated annual effective income tax rate, subject to adjustments for discrete events, should they occur. The effective tax rates used in the calculation of income taxes were 37.9% and 34.8% for the three months ended June 30, 2016 and 2015, respectively. The increase in the effective tax rate for the three months ended June 30, 2016 was primarily due to higher marginal tax rates that apply in the current year period related to the agreement to sell Pediacare , New Skin and Fiber Choice . See Note 3 above. During the three months ended June 30, 2016, we realized a net reduction to our deferred tax liability of $19.4 million as a result of the agreement to sell Pediacare , New Skin and Fiber Choice . At June 30, 2016, a 100% owned subsidiary of the Company had a net operating loss carryforward of approximately $20.9 million ( $7.4 million , tax effected), which may be used to offset future taxable income of the consolidated group and begins to expire in 2025. The Company expects to fully utilize the loss carryover before it expires. The net operating loss carryforward is subject to an annual limitation as to usage under Internal Revenue Code Section 382 of approximately $33.6 million . The balance in our uncertain tax liability was $4.1 million at June 30, 2016 and March 31, 2016. We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. We did not incur any material interest or penalties related to income taxes in any of the periods presented.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies We are involved from time to time in legal matters and other claims incidental to our business. We review outstanding claims and proceedings internally and with external counsel as necessary to assess the probability and amount of a potential loss. These assessments are re-evaluated at each reporting period and as new information becomes available to determine whether a reserve should be established or if any existing reserve should be adjusted. The actual cost of resolving a claim or proceeding ultimately may be substantially different than the amount of the recorded reserve. In addition, because it is not permissible under GAAP to establish a litigation reserve until the loss is both probable and estimable, in some cases there may be insufficient time to establish a reserve prior to the actual incurrence of the loss (upon verdict and judgment at trial, for example, or in the case of a quickly negotiated settlement). We believe the resolution of routine legal matters and other claims incidental to our business, taking our reserves into account, will not have a material adverse effect on our business, financial condition, or results of operations. Lease Commitments We have operating leases for office facilities and equipment in New York and other locations, which expire at various dates through fiscal 2022. These amounts have been included in the table below. The following summarizes future minimum lease payments for our operating leases as of June 30, 2016 (a) : (In thousands) Year Ending March 31, Facilities Equipment Total 2017 (Remaining nine months ending March 31, 2017) $ 1,522 $ 34 $ 1,556 2018 2,015 — 2,015 2019 2,009 — 2,009 2020 1,842 — 1,842 2021 903 — 903 Thereafter 59 — 59 $ 8,350 $ 34 $ 8,384 (a) Minimum lease payments have not been reduced by minimum sublease rentals of $1.1 million due to us in the future under noncancelable subleases. The following schedule shows the composition of total minimum lease payments that have been reduced by minimum sublease rentals: (In thousands) June 30, 2016 March 31, 2016 Minimum lease payments $ 8,384 $ 8,434 Less: Sublease rentals (1,100 ) (1,165 ) $ 7,284 $ 7,269 Rent expense for the three months ended June 30, 2016 and 2015 was $0.6 million and $0.4 million , respectively. Purchase Commitments Effective November 1, 2009, we entered into a ten year supply agreement for the exclusive manufacture of a portion of one of our Household Cleaning products. Although we are committed under the supply agreement to pay the minimum amounts set forth in the table below, the total commitment is less than 10% of the estimated purchases that we expect to make during the course of the agreement. (In thousands) Year Ending March 31, Amount 2017 (Remaining nine months ending March 31, 2017) 803 2018 1,013 2019 982 2020 560 2021 — $ 3,358

Concentrations of Risk

Concentrations of Risk	3 Months Ended
	Jun. 30, 2016
Risks and Uncertainties [Abstract]
Concentrations of Risk	Concentrations of Risk Our revenues are concentrated in the areas of OTC Healthcare and Household Cleaning products. We sell our products to mass merchandisers, food and drug stores, and convenience, dollar and club stores. During the three months ended June 30, 2016 and 2015, approximately 42.3% and 43.9% , respectively, of our total revenues were derived from our five top selling brands. One customer, Walmart, accounted for more than 10% of our gross revenues for each of the periods presented. Walmart accounted for approximately 20.7% and 19.9% of our gross revenues for the three months ended June 30, 2016 and 2015, respectively. Our next largest customer, Walgreens, accounted for approximately 10.3% and 9.4% of gross revenues for the three months ended June 30, 2016 and 2015, respectively. At June 30, 2016 , approximately 23.2% and 10.2% of accounts receivable were owed by Walmart and Walgreens, respectively. We manage product distribution in the continental United States through a third-party distribution center in St. Louis, Missouri. A serious disruption, such as a flood or fire, to the main distribution center could damage our inventories and could materially impair our ability to distribute our products to customers in a timely manner or at a reasonable cost. We could incur significantly higher costs and experience longer lead times associated with the distribution of our products to our customers during the time that it takes us to reopen or replace our distribution center. As a result, any such disruption could have a material adverse effect on our business, sales and profitability. At June 30, 2016 , we had relationships with 102 third-party manufacturers. Of those, we had long-term contracts with 55 manufacturers that produced items that accounted for approximately 79.7% of gross sales for the three months ended June 30, 2016 . At June 30, 2015 , we had relationships with 98 third-party manufacturers. Of those, we had long-term contracts with 47 manufacturers that produced items that accounted for approximately 83.9% of gross sales for the three months ended June 30, 2015 . The fact that we do not have long-term contracts with certain manufacturers means that they could cease manufacturing our products at any time and for any reason or initiate arbitrary and costly price increases, which could have a material adverse effect on our business and results from operations. Although we are in the process of negotiating long-term contracts with certain key manufacturers, we may not be able to reach an agreement, which could have a material adverse effect on our business and results of operations.

Business Segments

Business Segments	3 Months Ended
	Jun. 30, 2016
Segment Reporting [Abstract]
Business Segments	Business Segments Segment information has been prepared in accordance with the Segment Reporting topic of the FASB ASC 280. Our current reportable segments consist of (i) North American OTC Healthcare, (ii) International OTC Healthcare and (iii) Household Cleaning. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and promotional expenses. The tables below summarize information about our reportable segments. Three Months Ended June 30, 2016 (In thousands) North American OTC International OTC Household Cleaning Consolidated Gross segment revenues $ 173,301 $ 15,800 $ 20,890 $ 209,991 Elimination of intersegment revenues (1,221 ) — — (1,221 ) Third-party segment revenues 172,080 15,800 20,890 208,770 Other revenues — 4 801 805 Total segment revenues 172,080 15,804 21,691 209,575 Cost of sales 65,718 5,464 16,802 87,984 Gross profit 106,362 10,340 4,889 121,591 Advertising and promotion 25,040 2,124 471 27,635 Contribution margin $ 81,322 $ 8,216 $ 4,418 93,956 Other operating expenses* 81,742 Operating income 12,214 Other expense 21,127 Loss before income taxes (8,913 ) Benefit for income taxes (3,382 ) Net loss $ (5,531 ) *Other operating expenses includes a pre-tax loss on sale of assets of $55.5 million recognized for assets held for sale related to Pediacare , New Skin and Fiber Choice. These assets and corresponding contribution margin are included within the North American OTC Healthcare segment. Three Months Ended June 30, 2015 (In thousands) North American OTC International OTC Household Cleaning Consolidated Gross segment revenues $ 156,339 $ 14,209 $ 21,467 $ 192,015 Elimination of intersegment revenues (728 ) — — (728 ) Third-party segment revenues 155,611 14,209 21,467 191,287 Other revenues** 15 25 805 845 Total segment revenues 155,626 14,234 22,272 192,132 Cost of sales** 58,503 4,913 16,480 79,896 Gross profit 97,123 9,321 5,792 112,236 Advertising and promotion 23,195 2,723 504 26,422 Contribution margin $ 73,928 $ 6,598 $ 5,288 85,814 Other operating expenses 23,309 Operating income 62,505 Other expense 22,335 Income before income taxes 40,170 Provision for income taxes 13,997 Net income $ 26,173 ** Certain immaterial amounts relating to other revenues and cost of sales were reclassified between the International OTC Healthcare segment and the North American OTC Healthcare segment. There were no changes to the consolidated financial statements for any periods presented. The tables below summarize information about our segment revenues from similar product groups. Three Months Ended June 30, 2016 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 28,126 $ 527 $ — $ 28,653 Cough & Cold 17,967 4,392 — 22,359 Women's Health 32,887 936 — 33,823 Gastrointestinal 19,106 4,256 — 23,362 Eye & Ear Care 26,007 2,796 — 28,803 Dermatologicals 22,698 671 — 23,369 Oral Care 23,811 2,217 — 26,028 Other OTC 1,478 9 — 1,487 Household Cleaning — — 21,691 21,691 Total segment revenues $ 172,080 $ 15,804 $ 21,691 $ 209,575 Three Months Ended June 30, 2015 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 26,848 $ 530 $ — $ 27,378 Cough & Cold 19,759 4,506 — 24,265 Women's Health 32,908 700 — 33,608 Gastrointestinal 20,320 3,808 — 24,128 Eye & Ear Care 24,307 3,955 — 28,262 Dermatologicals 20,095 534 — 20,629 Oral Care 9,977 194 — 10,171 Other OTC 1,412 7 — 1,419 Household Cleaning — — 22,272 22,272 Total segment revenues $ 155,626 $ 14,234 $ 22,272 $ 192,132 During the three months ended June 30, 2016 and 2015, approximately 87.5% and 87.3% , respectively, of our total segment revenues were from customers in the United States. Other than the United States, no individual geographical area accounted for more than 10% of net sales in any of the periods presented. During the three months ended June 30, 2016, our Canada and Australia sales accounted for approximately 4.7% and 5.0% , respectively, of our total segment revenues, while during the three months ended June 30, 2015, approximately 5.1% and 5.7% , respectively, of our total segment revenues were attributable to sales to Canada and Australia. At June 30, 2016 and March 31, 2016, approximately 95.9% of our consolidated goodwill and intangible assets were located in the United States and approximately 4.1% were located in Australia. These consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: June 30, 2016 (In thousands) North American OTC International OTC Household Cleaning Consolidated Goodwill $ 327,695 $ 22,030 $ 6,800 $ 356,525 Intangible assets Indefinite-lived 1,786,666 83,356 110,272 1,980,294 Finite-lived 219,570 1,453 22,242 243,265 Intangible assets, net 2,006,236 84,809 132,514 2,223,559 Total $ 2,333,931 $ 106,839 $ 139,314 $ 2,580,084 March 31, 2016 (In thousands) North American OTC International OTC Household Consolidated Goodwill $ 330,615 $ 22,776 $ 6,800 $ 360,191 Intangible assets Indefinite-lived 1,823,873 85,901 110,272 2,020,046 Finite-lived 277,762 2,237 22,678 302,677 Intangible assets, net 2,101,635 88,138 132,950 2,322,723 Total $ 2,432,250 $ 110,914 $ 139,750 $ 2,682,914

Condensed Consolidating Financi

Condensed Consolidating Financial Statements	3 Months Ended
	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidating Financial Statements	Condensed Consolidating Financial Statements As described in Note 10, Prestige Brands Holdings, Inc., together with certain of our 100% owned subsidiaries, has fully and unconditionally guaranteed, on a joint and several basis, the obligations of Prestige Brands, Inc. (a 100% owned subsidiary of the Company) set forth in the indentures governing the 2016 Senior Notes and the 2013 Senior Notes, including the obligation to pay principal and interest with respect to the 2016 Senior Notes and the 2013 Senior Notes. The 100% owned subsidiaries of the Company that have guaranteed the 2016 Senior Notes and the 2013 Senior Notes are as follows: Prestige Services Corp., Prestige Brands Holdings, Inc. (a Virginia corporation), Prestige Brands International, Inc., Medtech Holdings, Inc., Medtech Products Inc., The Cutex Company, The Spic and Span Company, Blacksmith Brands, Inc., Insight Pharmaceuticals Corporation, Insight Pharmaceuticals, LLC, Practical Health Products, Inc., and DenTek Holdings, Inc. (collectively, the "Subsidiary Guarantors"). A significant portion of our operating income and cash flow is generated by our subsidiaries. As a result, funds necessary to meet Prestige Brands, Inc.'s debt service obligations are provided in part by distributions or advances from our subsidiaries. Under certain circumstances, contractual and legal restrictions, as well as the financial condition and operating requirements of our subsidiaries, could limit Prestige Brands, Inc.'s ability to obtain cash from our subsidiaries for the purpose of meeting our debt service obligations, including the payment of principal and interest on the 2016 Senior Notes and the 2013 Senior Notes. Although holders of the 2016 Senior Notes and the 2013 Senior Notes will be direct creditors of the guarantors of the 2016 Senior Notes and the 2013 Senior Notes by virtue of the guarantees, we have indirect subsidiaries located primarily in the United Kingdom, the Netherlands and Australia (collectively, the "Non-Guarantor Subsidiaries") that have not guaranteed the 2016 Senior Notes or the 2013 Senior Notes, and such subsidiaries will not be obligated with respect to the 2016 Senior Notes or the 2013 Senior Notes. As a result, the claims of creditors of the Non-Guarantor Subsidiaries will effectively have priority with respect to the assets and earnings of such companies over the claims of the holders of the 2016 Senior Notes and the 2013 Senior Notes. Presented below are supplemental Condensed Consolidating Balance Sheets as of June 30, 2016 and March 31, 2016 , Condensed Consolidating Statements of Operations and Comprehensive Income for the three months ended June 30, 2016 and 2015 , and Condensed Consolidating Statements of Cash Flows for the three months ended June 30, 2016 and 2015 . Such consolidating information includes separate columns for: a) Prestige Brands Holdings, Inc., the parent, b) Prestige Brands, Inc., the Issuer or the Borrower, c) Combined Subsidiary Guarantors, d) Combined Non-Guarantor Subsidiaries, and e) Elimination entries necessary to consolidate the Company and all of its subsidiaries. The Condensed Consolidating Financial Statements are presented using the equity method of accounting for investments in our 100% owned subsidiaries. Under the equity method, the investments in subsidiaries are recorded at cost and adjusted for our share of the subsidiaries' cumulative results of operations, capital contributions, distributions and other equity changes. The elimination entries principally eliminate investments in subsidiaries and intercompany balances and transactions. The financial information in this note should be read in conjunction with the Consolidated Financial Statements presented and other notes related thereto contained in this Quarterly Report on Form 10-Q. Condensed Consolidating Statements of Operations and Comprehensive Income Three Months Ended June 30, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Brands, Inc., the issuer Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Revenues Net sales $ — $ 27,959 $ 168,205 $ 13,826 $ (1,220 ) $ 208,770 Other revenues — 75 801 486 (557 ) 805 Total revenues — 28,034 169,006 14,312 (1,777 ) 209,575 Cost of Sales Cost of sales (exclusive of depreciation shown below) — 12,086 71,462 6,000 (1,564 ) 87,984 Gross profit — 15,948 97,544 8,312 (213 ) 121,591 Operating Expenses Advertising and promotion — 4,745 20,804 2,086 — 27,635 General and administrative 1,937 2,188 14,314 1,018 — 19,457 Depreciation and amortization 920 151 5,633 128 — 6,832 Loss on sale of assets — — 55,453 — — 55,453 Total operating expenses 2,857 7,084 96,204 3,232 — 109,377 Operating income (loss) (2,857 ) 8,864 1,340 5,080 (213 ) 12,214 Other (income) expense Interest income (11,967 ) (21,262 ) (1,274 ) (159 ) 34,605 (57 ) Interest expense 8,440 21,174 24,901 1,274 (34,605 ) 21,184 Equity in (income) loss of subsidiaries 5,738 (31,333 ) (3,076 ) — 28,671 — Total other expense (income) 2,211 (31,421 ) 20,551 1,115 28,671 21,127 (Loss) income before income taxes (5,068 ) 40,285 (19,211 ) 3,965 (28,884 ) (8,913 ) (Benefit) provision for income taxes 463 3,178 (7,912 ) 889 — (3,382 ) Net (loss) income $ (5,531 ) $ 37,107 $ (11,299 ) $ 3,076 $ (28,884 ) $ (5,531 ) Comprehensive (loss) income, net of tax: Currency translation adjustments (5,824 ) (5,824 ) (5,824 ) (5,824 ) 17,472 (5,824 ) Total other comprehensive (loss) income (5,824 ) (5,824 ) (5,824 ) (5,824 ) 17,472 (5,824 ) Comprehensive (loss) income $ (11,355 ) $ 31,283 $ (17,123 ) $ (2,748 ) $ (11,412 ) $ (11,355 ) Condensed Consolidating Statements of Income and Comprehensive Income Three Months Ended June 30, 2015 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Revenues Net sales $ — $ 27,883 $ 152,524 $ 11,608 $ (728 ) $ 191,287 Other revenues — 96 819 498 (568 ) 845 Total revenues — 27,979 153,343 12,106 (1,296 ) 192,132 Cost of Sales Cost of sales (exclusive of depreciation shown below) — 10,441 66,378 4,408 (1,331 ) 79,896 Gross profit — 17,538 86,965 7,698 35 112,236 Operating Expenses Advertising and promotion — 2,517 21,228 2,677 — 26,422 General and administrative 1,315 2,555 11,951 1,768 — 17,589 Depreciation and amortization 989 146 4,445 140 — 5,720 Total operating expenses 2,304 5,218 37,624 4,585 — 49,731 Operating income (loss) (2,304 ) 12,320 49,341 3,113 35 62,505 Other (income) expense Interest income (12,049 ) (21,408 ) (1,220 ) (112 ) 34,762 (27 ) Interest expense 8,490 21,908 25,055 1,220 (34,762 ) 21,911 Loss on extinguishment of debt — 451 — — — 451 Equity in (income) loss of subsidiaries (25,306 ) (16,955 ) (1,450 ) — 43,711 — Total other (income) expense (28,865 ) (16,004 ) 22,385 1,108 43,711 22,335 Income (loss) before income taxes 26,561 28,324 26,956 2,005 (43,676 ) 40,170 Provision for income taxes 388 4,025 9,029 555 — 13,997 Net income (loss) $ 26,173 $ 24,299 $ 17,927 $ 1,450 $ (43,676 ) $ 26,173 Comprehensive income, net of tax: Currency translation adjustments (405 ) (405 ) (405 ) (405 ) 1,215 (405 ) Total other comprehensive income (loss) (405 ) (405 ) (405 ) (405 ) 1,215 (405 ) Comprehensive income (loss) $ 25,768 $ 23,894 $ 17,522 $ 1,045 $ (42,461 ) $ 25,768 Condensed Consolidating Balance Sheet June 30, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 5,311 $ — $ 2,278 $ 21,288 $ — $ 28,877 Accounts receivable, net — 10,167 69,646 8,624 — 88,437 Inventories — 10,017 73,711 9,884 (745 ) 92,867 Deferred income tax assets 325 826 8,812 739 — 10,702 Prepaid expenses and other current assets 9,012 538 8,365 815 — 18,730 Assets held for sale — — 41,745 — — 41,745 Total current assets 14,648 21,548 204,557 41,350 (745 ) 281,358 Property and equipment, net 8,624 216 5,641 599 — 15,080 Goodwill — 66,007 268,490 22,028 — 356,525 Intangible assets, net — 191,655 1,946,309 85,595 — 2,223,559 Other long-term assets — 1,918 — — — 1,918 Intercompany receivables 1,460,733 2,664,832 1,249,875 11,046 (5,386,486 ) — Investment in subsidiary 1,631,033 1,553,227 77,679 — (3,261,939 ) — Total Assets $ 3,115,038 $ 4,499,403 $ 3,752,551 $ 160,618 $ (8,649,170 ) $ 2,878,440 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 1,384 $ 6,922 $ 24,731 $ 1,975 $ — $ 35,012 Accrued interest payable — 9,216 — — — 9,216 Other accrued liabilities 7,991 2,137 39,617 6,168 — 55,913 Total current liabilities 9,375 18,275 64,348 8,143 — 100,141 Long-term debt Principal amount — 1,602,500 — — — 1,602,500 Less unamortized debt costs — (25,086 ) — — — (25,086 ) Long-term debt, net — 1,577,414 — — — 1,577,414 Deferred income tax liabilities — 60,847 399,323 387 — 460,557 Other long-term liabilities — — 2,682 165 — 2,847 Intercompany payables 2,368,182 1,243,701 1,697,409 77,194 (5,386,486 ) — Total Liabilities 2,377,557 2,900,237 2,163,762 85,889 (5,386,486 ) 2,140,959 Stockholders' Equity Common stock 532 — — — — 532 Additional paid-in capital 451,075 1,280,947 1,359,921 78,774 (2,719,642 ) 451,075 Treasury stock, at cost (6,558 ) — — — — (6,558 ) Accumulated other comprehensive (loss) income, net of tax (29,349 ) (29,349 ) (29,349 ) (29,349 ) 88,047 (29,349 ) Retained earnings (accumulated deficit) 321,781 347,568 258,217 25,304 (631,089 ) 321,781 Total Stockholders' Equity 737,481 1,599,166 1,588,789 74,729 (3,262,684 ) 737,481 Total Liabilities and Stockholders' Equity $ 3,115,038 $ 4,499,403 $ 3,752,551 $ 160,618 $ (8,649,170 ) $ 2,878,440 Condensed Consolidating Balance Sheet March 31, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 4,440 $ — $ 2,899 $ 19,891 $ — $ 27,230 Accounts receivable, net — 12,025 74,446 8,776 — 95,247 Inventories — 9,411 72,296 10,088 (532 ) 91,263 Deferred income tax assets 316 681 8,293 818 — 10,108 Prepaid expenses and other current assets 15,311 257 8,379 1,218 — 25,165 Total current assets 20,067 22,374 166,313 40,791 (532 ) 249,013 Property and equipment, net 9,166 210 5,528 636 — 15,540 Goodwill — 66,007 271,409 22,775 — 360,191 Intangible assets, net — 191,789 2,042,640 88,294 — 2,322,723 Other long-term assets — 1,324 — — — 1,324 Intercompany receivables 1,457,011 2,703,192 1,083,488 10,738 (5,254,429 ) — Investment in subsidiary 1,641,477 1,527,718 81,545 — (3,250,740 ) — Total Assets $ 3,127,721 $ 4,512,614 $ 3,650,923 $ 163,234 $ (8,505,701 ) $ 2,948,791 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 2,914 $ 7,643 $ 24,437 $ 3,302 $ — $ 38,296 Accrued interest payable — 8,664 — — — 8,664 Other accrued liabilities 12,285 1,714 38,734 6,991 — 59,724 Total current liabilities 15,199 18,021 63,171 10,293 — 106,684 Long-term debt Principal amount — 1,652,500 — — — 1,652,500 Less unamortized debt costs — (27,191 ) — — — (27,191 ) Long-term debt, net — 1,625,309 — — — 1,625,309 Deferred income tax liabilities — 60,317 408,893 412 — 469,622 Other long-term liabilities — — 2,682 158 — 2,840 Intercompany payables 2,368,186 1,241,084 1,570,265 74,894 (5,254,429 ) — Total Liabilities 2,383,385 2,944,731 2,045,011 85,757 (5,254,429 ) 2,204,455 Stockholders' Equity Common stock 530 — — — — 530 Additional paid-in capital 445,182 1,280,947 1,359,921 78,774 (2,719,642 ) 445,182 Treasury stock, at cost (5,163 ) — — — — (5,163 ) Accumulated other comprehensive income (loss), net of tax (23,525 ) (23,525 ) (23,525 ) (23,525 ) 70,575 (23,525 ) Retained earnings (accumulated deficit) 327,312 310,461 269,516 22,228 (602,205 ) 327,312 Total Stockholders' Equity 744,336 1,567,883 1,605,912 77,477 (3,251,272 ) 744,336 Total Liabilities and Stockholders' Equity $ 3,127,721 $ 4,512,614 $ 3,650,923 $ 163,234 $ (8,505,701 ) $ 2,948,791 Condensed Consolidating Statement of Cash Flows Three Months Ended June 30, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Operating Activities Net (loss) income $ (5,531 ) $ 37,107 $ (11,299 ) $ 3,076 $ (28,884 ) $ (5,531 ) Adjustments to reconcile net (loss) income to net cash provided by operating activities: Depreciation and amortization 920 151 5,633 128 — 6,832 Loss on sale of assets — — 55,453 — — 55,453 Deferred income taxes (9 ) 385 (10,089 ) 53 — (9,660 ) Amortization of debt origination costs — 2,231 — — — 2,231 Stock-based compensation costs 1,940 — — — — 1,940 Equity in income of subsidiaries 5,738 (31,333 ) (3,076 ) — 28,671 — Changes in operating assets and liabilities, net of effects from acquisitions: Accounts receivable — 1,858 4,800 (1,507 ) — 5,151 Inventories — (606 ) (3,835 ) (99 ) 213 (4,327 ) Prepaid expenses and other current assets 6,299 (281 ) (697 ) 376 — 5,697 Accounts payable (1,556 ) (721 ) 109 (1,233 ) — (3,401 ) Accrued liabilities (4,294 ) 975 261 (576 ) — (3,634 ) Net cash provided by operating activities 3,507 9,766 37,260 218 — 50,751 Investing Activities Purchases of property and equipment (225 ) (23 ) (596 ) (51 ) — (895 ) Net cash used in investing activities (225 ) (23 ) (596 ) (51 ) — (895 ) Financing Activities Term loan repayments — (50,000 ) — — — (50,000 ) Payments of debt origination costs — (9 ) — — — (9 ) Proceeds from exercise of stock options 3,405 — — — — 3,405 Excess tax benefits from share-based awards 550 — — — — 550 Fair value of shares surrendered as payment of tax withholding (1,395 ) — — — — (1,395 ) Intercompany activity, net (4,971 ) 40,266 (37,285 ) 1,990 — — Net cash (used in) provided by financing activities (2,411 ) (9,743 ) (37,285 ) 1,990 — (47,449 ) Effect of exchange rate changes on cash and cash equivalents — — — (760 ) — (760 ) Increase (decrease) in cash and cash equivalents 871 — (621 ) 1,397 — 1,647 Cash and cash equivalents - beginning of period 4,440 — 2,899 19,891 — 27,230 Cash and cash equivalents - end of period $ 5,311 $ — $ 2,278 $ 21,288 $ — $ 28,877 Condensed Consolidating Statement of Cash Flows Three Months Ended June 30, 2015 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non-Guarantor Subsidiaries Eliminations Consolidated Operating Activities Net income (loss) $ 26,173 $ 24,299 $ 17,927 $ 1,450 $ (43,676 ) $ 26,173 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization 989 146 4,445 140 — 5,720 Gain on sale of asset — — — (36 ) — (36 ) Deferred income taxes 141 395 10,866 134 — 11,536 Amortization of debt origination costs — 2,138 — — — 2,138 Stock-based compensation costs 3,047 — — — — 3,047 Loss on extinguishment of debt — 451 — — — 451 Equity in income of subsidiaries (25,306 ) (16,955 ) (1,450 ) — 43,711 — Changes in operating assets and liabilities, net of effects from acquisitions: Accounts receivable — 3,171 735 (1,328 ) — 2,578 Inventories — 1,175 (1,457 ) 106 (35 ) (211 ) Prepaid expenses and other current assets (2,152 ) (102 ) 722 10 — (1,522 ) Accounts payable 861 (325 ) 880 (633 ) — 783 Accrued liabilities (5,668 ) (2,368 ) 975 (75 ) — (7,136 ) Net cash provided by (used in) operating activities (1,915 ) 12,025 33,643 (232 ) — 43,521 Investing Activities Purchases of property and equipment (648 ) — (27 ) (105 ) — (780 ) Proceeds from the sale of property and equipment — — — 344 — 344 Net cash (used in) provided by investing activities (648 ) — (27 ) 239 — (436 ) Financing Activities Term loan repayments — (25,000 ) — — — (25,000 ) Borrowings under revolving credit agreement — 15,000 — — — 15,000 Repayments under revolving credit agreement — (35,000 ) — — — (35,000 ) Payments of debt origination costs — (4,172 ) — — — (4,172 ) Proceeds from exercise of stock options 6,328 — — — — 6,328 Proceeds from restricted stock exercises 544 — — — — 544 Excess tax benefits from share-based awards 1,600 — — — — 1,600 Fair value of shares surrendered as payment of tax withholding (2,187 ) — — — — (2,187 ) Intercompany activity, net (4,277 ) 37,147 (33,616 ) 746 — — Net cash (used in) provided by financing activities 2,008 (12,025 ) (33,616 ) 746 — (42,887 ) Effect of exchange rate changes on cash and cash equivalents — — — 82 — 82 Increase (decrease) in cash and cash equivalents (555 ) — — 835 — 280 Cash and cash equivalents - beginning of period 11,387 — — 9,931 — 21,318 Cash and cash equivalents - end of period $ 10,832 $ — $ — $ 10,766 $ — $ 21,598

Subsequent Events

Subsequent Events	3 Months Ended
	Jun. 30, 2016
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Divestitures Sale of Pediacare, New Skin and Fiber Choice brands On July 7, 2016, we divested the Pediacare, New Skin and Fiber Choice brands, which were non-core OTC brands. As a result, we received approximately $40.1 million including inventory, less certain immaterial holdbacks which will be paid upon meeting certain criteria as defined in the agreement. The proceeds were used to repay debt. We recorded a pre-tax loss of approximately $55.5 million as a result of the sale. Concurrent with the completion of the sale of these brands, we entered into a Transitional Services Agreement with the buyer, whereby we agreed to provide the buyer with various services, including marketing, operations, finance and other services from the date of the acquisition through January 7, 2017. We also entered into an option agreement with the buyer to purchase Dermoplast at a specified earnings multiple as defined in the agreement. The buyer must notify us of its election to purchase the option and pay a $1.25 million deposit within ninety days of closing and complete the transaction by December 31, 2017. Chief Financial Officer Resignation: On July 14, 2016, David Marberger, our Chief Financial Officer, resigned effective August 5, 2016. Following his resignation, and effective August 5, 2016, Ron Lombardi, our President and Chief Executive Officer and member of the Board of Directors, will succeed Mr. Marberger as interim Chief Financial Officer. The Company has commenced a search for a new Chief Financial Officer. Royalty Income Historically, we received royalty income from the licensing of the names of certain of our brands in geographic areas or markets in which we do not directly compete. We have had royalty agreements for our Comet brand for several years, which included options on behalf of the licensee to purchase license rights in certain geographic areas and markets in perpetuity. In December 2014, we amended these agreements and we sold rights to use of the Comet brand in certain Eastern European countries to a third-party licensee in exchange for $10.0 million as a partial early buyout. However, we continued to receive royalty payments of $1.0 million per quarter for the remaining geographic areas. The amendments also granted the licensee the right to exercise an option to acquire the license rights in the remaining geographic areas anytime after June 30, 2016. In July 2016, the licensee elected to exercise its option, as defined in the amended agreement. As a result, the licensee will no longer be required to make quarterly payments to us and our quarterly royalty income will be reduced by approximately $0.8 million beginning in the second quarter of 2017, when we expect to close on this transaction. Issuance of Restricted Stock Units Pursuant to the Plan, each of the independent members of the Board of Directors received a grant of 1,896 restricted stock units on August 2, 2016. The restricted stock units vest on August 2, 2017 and shall be settled by delivery to the director of one share of common stock of the Company for each vested restricted stock unit promptly following the earliest of the director's (i) death, (ii) disability or (iii) the six -month anniversary of the date on which the director's Board membership ceases for reasons other than death or disability.

Business and Basis of Present27

Business and Basis of Presentation (Policies)	3 Months Ended
	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The unaudited Consolidated Financial Statements presented herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. All significant intercompany transactions and balances have been eliminated in these Consolidated Financial Statements. In the opinion of management, these Consolidated Financial Statements include all adjustments, consisting of normal recurring adjustments, that are considered necessary for a fair statement of our consolidated financial position, results of operations and cash flows for the interim periods presented. Our fiscal year ends on March 31 st of each year. References in these Consolidated Financial Statements or related notes to a year (e.g., “2017”) mean our fiscal year ending or ended on March 31 st of that year. Operating results for the three months ended June 30, 2016 are not necessarily indicative of results that may be expected for the fiscal year ending March 31, 2017 . These unaudited Consolidated Financial Statements and related notes should be read in conjunction with our audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2016 .
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates. As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances and inventory obsolescence, and the recognition of income taxes using an estimated annual effective tax rate.
Cash and Cash Equivalents	Cash and Cash Equivalents We consider all short-term deposits and investments with original maturities of three months or less to be cash equivalents. Substantially all of our cash is held by a large regional bank with headquarters in California. We do not believe that, as a result of this concentration, we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships. The Federal Deposit Insurance Corporation (“FDIC”) and Securities Investor Protection Corporation (“SIPC”) insure these balances up to $250,000 and $500,000, with a $250,000 limit for cash, respectively. Substantially all of the Company's cash balances at June 30, 2016 are uninsured.
Accounts Receivable	Accounts Receivable We extend non-interest-bearing trade credit to our customers in the ordinary course of business. We maintain an allowance for doubtful accounts receivable based upon historical collection experience and expected collectability of the accounts receivable. In an effort to reduce credit risk, we (i) have established credit limits for all of our customer relationships, (ii) perform ongoing credit evaluations of customers' financial condition, (iii) monitor the payment history and aging of customers' receivables, and (iv) monitor open orders against an individual customer's outstanding receivable balance.
Inventories	Inventories Inventories are stated at the lower of cost or market value, with cost determined by using the first-in, first-out method. We reduce inventories for diminution of value resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value. Factors utilized in the determination of estimated market value include: (i) current sales data and historical return rates, (ii) estimates of future demand, (iii) competitive pricing pressures, (iv) new product introductions, (v) product expiration dates, and (vi) component and packaging obsolescence.
Assets Held for Sale	Assets Held for Sale We classify assets or disposal groups to be sold as held for sale in the period in which all of the following criteria are met: (i) management, having the authority to approve the action, commits to a plan to sell the asset or disposal group, (ii) the asset or disposal group is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets or disposal groups, (iii) an active program to locate a buyer and other actions required to compete the plan to sell the asset or disposal group have been initiated, (iv) the sale of the asset or disposal group is probable, and transfer of the asset or disposal group is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond our control extend the period of time required to complete the sale of the asset or disposal group beyond one year, (v) the asset or disposal group is being actively marketed for sale at a price that is reasonable in relation to its current fair value, and (vi) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. We measure an asset or disposal group that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held-for-sale criteria are met. Conversely, gains are not recognized on the sale of a long-lived asset or disposal group until the date of sale. We assess the fair value of a long-lived asset or disposal group less any costs to sell each reporting period it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset or disposal group, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale. Upon determining that an asset or disposal group meets the criteria as held for sale, the Company ceases depreciation and reports both long-lived assets and/or the current assets and liabilities of the disposal group, if material, in the line item assets held for sale in our consolidated balance sheet. Refer to Note 3 below for further discussion.
Property and Equipment	Property and Equipment Property and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives: Years Machinery 5 Computer equipment and software 3 Furniture and fixtures 7 Leasehold improvements * *Leasehold improvements are amortized over the lesser of the term of the lease or the estimated useful life of the related asset. Expenditures for maintenance and repairs are charged to expense as incurred. When an asset is sold or otherwise disposed of, we remove the cost and associated accumulated depreciation from the respective accounts and recognize the resulting gain or loss in the Consolidated Statements of Operations and Comprehensive Income. Property and equipment are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.
Goodwill	Goodwill The excess of the purchase price over the fair market value of assets acquired and liabilities assumed in business combinations is classified as goodwill. Goodwill is not amortized, although the carrying value is tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired. Goodwill is tested for impairment at the product group level, which is one level below the operating segment level.
Intangible Assets	Intangible Assets Intangible assets, which are comprised primarily of trademarks, are stated at cost less accumulated amortization. For intangible assets with finite lives, amortization is computed using the straight-line method over estimated useful lives, typically ranging from 10 to 30 years. Indefinite-lived intangible assets are tested for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that the asset may be impaired. Intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amounts may exceed their fair values and may not be recoverable. An impairment loss is recognized if the carrying amount of the asset exceeds its fair value.
Debt Origination Costs	Debt Origination Costs We have incurred debt origination costs in connection with the issuance of long-term debt. These costs are amortized over the term of the related debt, using the effective interest method for our term loan facility and the straight-line method for our revolving credit facility.
Revenue Recognition	Revenue Recognition Revenues are recognized when the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the selling price is fixed or determinable, (iii) the product has been shipped and the customer takes ownership and assumes the risk of loss, and (iv) collection of the resulting receivable is reasonably assured. We have determined that these criteria are met and the transfer of the risk of loss generally occurs when the product is received by the customer, and, accordingly, we recognize revenue at that time. Provisions are made for estimated discounts related to customer payment terms and estimated product returns at the time of sale based on our historical experience. As is customary in the consumer products industry, we participate in the promotional programs of our customers to enhance the sale of our products. The cost of these promotional programs varies based on the actual number of units sold during a finite period of time. These promotional programs consist of direct-to-consumer incentives, such as coupons and temporary price reductions, as well as incentives to our customers, such as allowances for new distribution, including slotting fees, and cooperative advertising. Estimates of the costs of these promotional programs are based on (i) historical sales experience, (ii) the current promotional offering, (iii) forecasted data, (iv) current market conditions, and (v) communication with customer purchasing/marketing personnel. We recognize the cost of such sales incentives by recording an estimate of such cost as a reduction of revenue, at the later of (a) the date the related revenue is recognized, or (b) the date when a particular sales incentive is offered. At the completion of a promotional program, the estimated amounts are adjusted to actual results. Due to the nature of the consumer products industry, we are required to estimate future product returns. Accordingly, we record an estimate of product returns concurrent with recording sales, which is made after analyzing (i) historical return rates, (ii) current economic trends, (iii) changes in customer demand, (iv) product acceptance, (v) seasonality of our product offerings, and (vi) the impact of changes in product formulation, packaging and advertising.
Cost of Sales	Cost of Sales Cost of sales includes product costs, warehousing costs, inbound and outbound shipping costs, and handling and storage costs.
Advertising and Promotion Costs	Advertising and Promotion Costs Advertising and promotion costs are expensed as incurred. Allowances for new distribution costs associated with products, including slotting fees, are recognized as a reduction of sales. Under these new distribution arrangements, the retailers allow our products to be placed on the stores' shelves in exchange for such fees.
Stock-based Compensation	Stock-based Compensation We recognize stock-based compensation by measuring the cost of services to be rendered based on the grant-date fair value of the equity award. Compensation expense is recognized over the period a grantee is required to provide service in exchange for the award, generally referred to as the requisite service period.
Income Taxes	Income Taxes Deferred tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amounts expected to be realized. The Income Taxes topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The guidance only allows the recognition of those tax benefits that have a greater than 50% likelihood of being sustained upon examination by the various taxing authorities. As a result, we have applied such guidance in determining our tax uncertainties. We are subject to taxation in the United States and various state and foreign jurisdictions. We classify penalties and interest related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Operations and Comprehensive Income.
Earnings Per Share	Earnings Per Share Basic earnings per share is calculated based on income available to common stockholders and the weighted-average number of shares outstanding during the reporting period. Diluted earnings per share is calculated based on income available to common stockholders and the weighted-average number of common and potential common shares outstanding during the reporting period. Potential common shares, composed of the incremental common shares issuable upon the exercise of outstanding stock options and unvested restricted stock units, are included in the earnings per share calculation to the extent that they are dilutive. In loss periods, the assumed exercise of in-the-money stock options and restricted stock units has an anti-dilutive effect and therefore, these instruments are excluded from the computation of diluted earnings per share.
Recently Issued Accounting Standards	Recently Issued Accounting Standards In May 2016, the FASB issued Accounting Standards Update ("ASU") 2016-12, Revenue from Contracts with Customers . The amendments do not change the core principle of the guidance in FASB ASC 606. Rather, the amendments in this update affect only certain narrow aspects of FASB ASC 606. The effective date and transition requirements for the amendments in this update are the same as the effective date and transition requirements of ASU 2014-09 described below. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers . The amendments in this update clarify the implementation guidance on identifying performance obligations and licensing in FASB ASC 606. The effective date and transition requirements for the amendments in this update are the same as the effective date and transition requirements of ASU 2014-09 described below. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting . The amendments in this update involve several aspects of accounting for share-based payment transactions, including income tax consequences, classification of awards, and classification on the statement of cash flows. For public business entities, the amendments in this update are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers . The amendments in this update clarify the implementation guidance on principals versus agent considerations in FASB ASC 606. The effective date and transition requirements for the amendments in this update are the same as the effective date and transition requirements of ASU 2014-09 described below. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In February 2016, the FASB issued ASU 2016-02, Leases. The amendments in this update include a new FASB ASC Topic 842, which supersedes Topic 840. The core principle of Topic 842 is that a lessee should recognize the assets and liabilities that arise from leases. For public business entities, the amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early application is permitted for all entities as of the beginning of interim or annual reporting periods. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes . The amendments in this update require that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The amendments in this update may be applied either prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. For public business entities, the amendments in this update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. Early application is permitted for all entities as of the beginning of interim or annual reporting periods. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements. In July 2015, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory . The amendments in this update more closely align the measurement of inventory in GAAP with the measurement of inventory in International Financial Reporting Standards, under which an entity should measure inventory at the lower of cost or net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. For public business entities, the amendments are effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The adoption of ASU 2015-11 is not expected to have a material impact on our Consolidated Financial Statements. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers - Topic 606 , which supersedes the revenue recognition requirements in FASB ASC 605. The new guidance primarily states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. In August 2015, the FASB issued ASU 2015-14, which deferred the effective date of ASU 2014-09 from annual and interim periods beginning after December 15, 2016 to annual and interim periods beginning after December 15, 2017. Earlier application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. We are evaluating the impact of adopting this guidance on our Consolidated Financial Statements.

Business and Basis of Present28

Business and Basis of Presentation (Tables)	3 Months Ended
	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Property and Equipment	Property and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives: Years Machinery 5 Computer equipment and software 3 Furniture and fixtures 7 Leasehold improvements * *Leasehold improvements are amortized over the lesser of the term of the lease or the estimated useful life of the related asset. Property and equipment consist of the following: (In thousands) June 30, March 31, Components of Property and Equipment Machinery $ 8,444 $ 7,734 Computer equipment 13,154 12,793 Furniture and fixtures 2,444 2,445 Leasehold improvements 7,384 7,389 31,426 30,361 Accumulated depreciation (16,346 ) (14,821 ) Property and equipment, net $ 15,080 $ 15,540

Acquisitions (Tables)

Acquisitions (Tables)	3 Months Ended
	Jun. 30, 2016
Business Combinations [Abstract]
Allocation of Assets Acquired and Liabilities Assumed	The following table summarizes our preliminary allocation of the assets acquired and liabilities assumed as of the February 5, 2016 acquisition date. (In thousands) February 5, 2016 Cash acquired $ 1,359 Accounts receivable 9,187 Inventories 14,304 Deferred income taxes 3,303 Prepaids and other current assets 6,728 Property, plant and equipment, net 3,555 Goodwill 76,529 Intangible assets, net 206,700 Total assets acquired 321,665 Accounts payable 3,261 Accrued expenses 16,488 Deferred income tax liabilities - long term 73,573 Total liabilities assumed 93,322 Total purchase price $ 228,343

Assets Held for Sale (Tables)

Assets Held for Sale (Tables)	3 Months Ended
	Jun. 30, 2016
Discontinued Operations and Disposal Groups [Abstract]
Disclosure of Total Assets Held for Sale	as of June 30, 2016, the total assets held for sale, net of the loss recognized, related to Pediacare , New Skin and Fiber Choice were: (In thousands) June 30, Components of assets held for sale: Inventory $ 2,420 Intangible assets, net 36,405 Goodwill 2,920 Assets held for sale $ 41,745

Accounts Receivable (Tables)

Accounts Receivable (Tables)	3 Months Ended
	Jun. 30, 2016
Receivables [Abstract]
Accounts Receivable	Accounts receivable consist of the following: (In thousands) June 30, March 31, Components of Accounts Receivable Trade accounts receivable $ 98,513 $ 105,592 Other receivables 1,046 1,261 99,559 106,853 Less allowances for discounts, returns and uncollectible accounts (11,122 ) (11,606 ) Accounts receivable, net $ 88,437 $ 95,247

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Jun. 30, 2016
Inventory Disclosure [Abstract]
Inventories	Inventories consist of the following: (In thousands) June 30, March 31, Components of Inventories Packaging and raw materials $ 7,442 $ 7,563 Finished goods 85,425 83,700 Inventories $ 92,867 $ 91,263

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Jun. 30, 2016
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and equipment are stated at cost and are depreciated using the straight-line method based on the following estimated useful lives: Years Machinery 5 Computer equipment and software 3 Furniture and fixtures 7 Leasehold improvements * *Leasehold improvements are amortized over the lesser of the term of the lease or the estimated useful life of the related asset. Property and equipment consist of the following: (In thousands) June 30, March 31, Components of Property and Equipment Machinery $ 8,444 $ 7,734 Computer equipment 13,154 12,793 Furniture and fixtures 2,444 2,445 Leasehold improvements 7,384 7,389 31,426 30,361 Accumulated depreciation (16,346 ) (14,821 ) Property and equipment, net $ 15,080 $ 15,540

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Reconciliation of the Activity Affecting Goodwill	A reconciliation of the activity affecting goodwill by operating segment is as follows: (In thousands) North American OTC Healthcare International OTC Healthcare Household Cleaning Consolidated Balance — March 31, 2016 $ 330,615 $ 22,776 $ 6,800 $ 360,191 Reclassified to assets held for sale (2,920 ) — — (2,920 ) Effects of foreign currency exchange rates — (746 ) — (746 ) Balance — June 30, 2016 $ 327,695 $ 22,030 $ 6,800 $ 356,525

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Reconciliation of the Activity Affecting Intangible Assets	A reconciliation of the activity affecting intangible assets is as follows: (In thousands) Indefinite Lived Trademarks Finite Lived Totals Gross Carrying Amounts Balance — March 31, 2016 $ 2,020,046 $ 417,880 $ 2,437,926 Reclassified to assets held for sale (37,207 ) (60,103 ) (97,310 ) Effects of foreign currency exchange rates (2,545 ) (107 ) (2,652 ) Balance — June 30, 2016 1,980,294 357,670 2,337,964 Accumulated Amortization Balance — March 31, 2016 — 115,203 115,203 Reclassified to assets held for sale — (6,102 ) (6,102 ) Additions — 5,313 5,313 Effects of foreign currency exchange rates — (9 ) (9 ) Balance — June 30, 2016 — 114,405 114,405 Intangible assets, net - June 30, 2016 $ 1,980,294 $ 243,265 $ 2,223,559 Intangible Assets, net by Reportable Segment: North American OTC Healthcare $ 1,786,666 $ 219,570 $ 2,006,236 International OTC Healthcare 83,356 1,453 84,809 Household Cleaning 110,272 22,242 132,514 Intangible assets, net - June 30, 2016 $ 1,980,294 $ 243,265 $ 2,223,559
Schedule of Expected Amortization Expense	At June 30, 2016 , finite-lived intangible assets are being amortized over a period of 10 to 30 years, and the associated amortization expense is expected to be as follows: (In thousands) Year Ending March 31, Amount 2017 (Remaining nine months ending March 31, 2017) $ 13,654 2018 18,049 2019 18,049 2020 18,049 2021 17,626 Thereafter 157,838 $ 243,265

Other Accrued Liabilities (Tabl

Other Accrued Liabilities (Tables)	3 Months Ended
	Jun. 30, 2016
Payables and Accruals [Abstract]
Other Accrued Liabilities	Other accrued liabilities consist of the following: (In thousands) June 30, March 31, Accrued marketing costs $ 29,410 $ 26,373 Accrued compensation costs 4,275 9,574 Accrued broker commissions 564 1,497 Income taxes payable 3,282 3,675 Accrued professional fees 2,226 1,787 Deferred rent 747 836 Accrued production costs 3,413 3,324 Accrued lease termination costs 417 448 Income tax related payable 6,354 6,354 Other accrued liabilities 5,225 5,856 $ 55,913 $ 59,724

Long-Term Debt (Tables)

Long-Term Debt (Tables)	3 Months Ended
	Jun. 30, 2016
Debt Disclosure [Abstract]
Schedule of Long-term Debt	Long-term debt consists of the following, as of the dates indicated: (In thousands, except percentages) June 30, March 31, 2016 Senior Notes bearing interest at 6.375%, with interest payable on March 1 and September 1 of each year. The 2016 Senior Notes mature on March 1, 2024. $ 350,000 $ 350,000 2013 Senior Notes bearing interest at 5.375%, with interest payable on June 15 and December 15 of each year. The 2013 Senior Notes mature on December 15, 2021. 400,000 400,000 2012 Term B-3 Loans bearing interest at the Borrower's option at either a base rate with a floor of 1.75% plus applicable margin or LIBOR with a floor of 0.75% plus applicable margin, due on September 3, 2021. 767,500 817,500 2012 ABL Revolver bearing interest at the Borrower's option at either a base rate plus applicable margin or LIBOR plus applicable margin. Any unpaid balance is due on June 9, 2020. 85,000 85,000 Total long-term debt (including current portion) 1,602,500 1,652,500 Current portion of long-term debt — — Long-term debt 1,602,500 1,652,500 Less: unamortized debt costs (25,086 ) (27,191 ) Long-term debt, net $ 1,577,414 $ 1,625,309
Aggregate Future Principal Payments	At June 30, 2016, aggregate future principal payments required in accordance with the terms of the 2012 Term Loan, 2012 ABL Revolver and the indentures governing the 2016 Senior Notes and the 2013 Senior Notes are as follows: (In thousands) Year Ending March 31, Amount 2017 (remaining nine months ending March 31, 2017) $ — 2018 — 2019 — 2020 — 2021 85,000 Thereafter 1,517,500 $ 1,602,500

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Jun. 30, 2016
Fair Value Disclosures [Abstract]
Summary of Carry Amounts and Fair Value Measurements	As such, the 2016 Senior Notes, the 2013 Senior Notes, the Term B-3 loans, and the 2012 ABL Revolver are measured in Level 2 of the above hierarchy (see summary below detailing the carrying amounts and estimated fair values of these borrowings at June 30, 2016 and March 31, 2016). June 30, 2016 March 31, 2016 (In thousands) Carrying Value Fair Value Carrying Value Fair Value 2016 Senior Notes $ 350,000 $ 359,625 $ 350,000 $ 363,125 2013 Senior Notes 400,000 404,000 400,000 408,000 Term B-3 Loans 767,500 766,541 817,500 818,522 2012 ABL Revolver 85,000 85,000 85,000 85,000

Accumulated Other Comprehensi39

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Jun. 30, 2016
Stockholders' Equity Note [Abstract]
Schedule of Accumulated Other Comprehensive Income	The table below presents accumulated other comprehensive loss (“AOCI”), which affects equity and results from recognized transactions and other economic events, other than transactions with owners in their capacity as owners. AOCI consisted of the following at June 30, 2016 and March 31, 2016 : June 30, March 31, (In thousands) 2016 2016 Components of Accumulated Other Comprehensive Loss Cumulative translation adjustment $ (29,349 ) $ (23,525 ) Accumulated other comprehensive loss, net of tax $ (29,349 ) $ (23,525 )

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Jun. 30, 2016
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended June 30, (In thousands, except per share data) 2016 2015 Numerator Net (loss) income $ (5,531 ) $ 26,173 Denominator Denominator for basic earnings per share — weighted average shares outstanding 52,881 52,548 Dilutive effect of unvested restricted stock units and options issued to employees and directors — 410 Denominator for diluted earnings per share 52,881 52,958 Earnings per Common Share: Basic net (loss) earnings per share $ (0.10 ) $ 0.50 Diluted net (loss) earnings per share $ (0.10 ) $ 0.49

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of Restricted Shares	A summary of the Company's restricted stock units granted under the Plan is presented below: Restricted Stock Units Shares (in thousands) Weighted- Average Grant-Date Fair Value Three months ended June 30, 2015 Vested and nonvested at March 31, 2015 362.3 $ 22.74 Granted 243.8 41.85 Vested and issued (138.9 ) 19.35 Forfeited (1.4 ) 33.50 Vested and nonvested at June 30, 2015 465.8 33.72 Vested at June 30, 2015 76.6 11.62 Three months ended June 30, 2016 Vested and nonvested at March 31, 2016 467.8 $ 35.22 Granted 49.4 57.16 Vested and issued (75.6 ) 31.36 Forfeited (76.2 ) 39.93 Vested and nonvested at June 30, 2016 365.4 38.00 Vested at June 30, 2016 70.2 14.89
Fair Value of Options Granted	Three months ended June 30, 2016 2015 Expected volatility 37.8 % 40.2 % Expected dividends $ — $ — Expected term in years 6.0 6.0 Risk-free rate 1.7 % 1.7 %
Stock Option Activity	A summary of option activity under the Plan is as follows: Options Shares (in thousands) Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in thousands) Three months ended June 30, 2015 Outstanding at March 31, 2015 871.2 $ 23.40 Granted 186.3 41.44 Exercised (330.4 ) 19.15 Forfeited or expired (0.9 ) 33.50 Outstanding at June 30, 2015 726.2 29.95 8.3 $ 11,830 Exercisable at June 30, 2015 322.5 21.54 7.2 7,966 Three months ended June 30, 2016 Outstanding at March 31, 2016 727.7 $ 30.70 Granted 224.8 57.18 Exercised (105.7 ) 32.20 Forfeited or expired (45.5 ) 37.34 Outstanding at June 30, 2016 801.3 37.55 8.0 $ 14,700 Exercisable at June 30, 2016 386.4 25.20 6.7 11,669

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases	The following summarizes future minimum lease payments for our operating leases as of June 30, 2016 (a) : (In thousands) Year Ending March 31, Facilities Equipment Total 2017 (Remaining nine months ending March 31, 2017) $ 1,522 $ 34 $ 1,556 2018 2,015 — 2,015 2019 2,009 — 2,009 2020 1,842 — 1,842 2021 903 — 903 Thereafter 59 — 59 $ 8,350 $ 34 $ 8,384 (a) Minimum lease payments have not been reduced by minimum sublease rentals of $1.1 million due to us in the future under noncancelable subleases. The following schedule shows the composition of total minimum lease payments that have been reduced by minimum sublease rentals: (In thousands) June 30, 2016 March 31, 2016 Minimum lease payments $ 8,384 $ 8,434 Less: Sublease rentals (1,100 ) (1,165 ) $ 7,284 $ 7,269
Purchase Commitments Minimum Amounts Set Forth	Although we are committed under the supply agreement to pay the minimum amounts set forth in the table below, the total commitment is less than 10% of the estimated purchases that we expect to make during the course of the agreement. (In thousands) Year Ending March 31, Amount 2017 (Remaining nine months ending March 31, 2017) 803 2018 1,013 2019 982 2020 560 2021 — $ 3,358

Business Segments (Tables)

Business Segments (Tables)	3 Months Ended
	Jun. 30, 2016
Segment Reporting [Abstract]
Information about our Operating and Reportable Segments	The tables below summarize information about our reportable segments. Three Months Ended June 30, 2016 (In thousands) North American OTC International OTC Household Cleaning Consolidated Gross segment revenues $ 173,301 $ 15,800 $ 20,890 $ 209,991 Elimination of intersegment revenues (1,221 ) — — (1,221 ) Third-party segment revenues 172,080 15,800 20,890 208,770 Other revenues — 4 801 805 Total segment revenues 172,080 15,804 21,691 209,575 Cost of sales 65,718 5,464 16,802 87,984 Gross profit 106,362 10,340 4,889 121,591 Advertising and promotion 25,040 2,124 471 27,635 Contribution margin $ 81,322 $ 8,216 $ 4,418 93,956 Other operating expenses* 81,742 Operating income 12,214 Other expense 21,127 Loss before income taxes (8,913 ) Benefit for income taxes (3,382 ) Net loss $ (5,531 ) *Other operating expenses includes a pre-tax loss on sale of assets of $55.5 million recognized for assets held for sale related to Pediacare , New Skin and Fiber Choice. These assets and corresponding contribution margin are included within the North American OTC Healthcare segment. Three Months Ended June 30, 2015 (In thousands) North American OTC International OTC Household Cleaning Consolidated Gross segment revenues $ 156,339 $ 14,209 $ 21,467 $ 192,015 Elimination of intersegment revenues (728 ) — — (728 ) Third-party segment revenues 155,611 14,209 21,467 191,287 Other revenues** 15 25 805 845 Total segment revenues 155,626 14,234 22,272 192,132 Cost of sales** 58,503 4,913 16,480 79,896 Gross profit 97,123 9,321 5,792 112,236 Advertising and promotion 23,195 2,723 504 26,422 Contribution margin $ 73,928 $ 6,598 $ 5,288 85,814 Other operating expenses 23,309 Operating income 62,505 Other expense 22,335 Income before income taxes 40,170 Provision for income taxes 13,997 Net income $ 26,173 ** Certain immaterial amounts relating to other revenues and cost of sales were reclassified between the International OTC Healthcare segment and the North American OTC Healthcare segment. There were no changes to the consolidated financial statements for any periods presented.
Information about our Revenues from Similar Product Groups	The tables below summarize information about our segment revenues from similar product groups. Three Months Ended June 30, 2016 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 28,126 $ 527 $ — $ 28,653 Cough & Cold 17,967 4,392 — 22,359 Women's Health 32,887 936 — 33,823 Gastrointestinal 19,106 4,256 — 23,362 Eye & Ear Care 26,007 2,796 — 28,803 Dermatologicals 22,698 671 — 23,369 Oral Care 23,811 2,217 — 26,028 Other OTC 1,478 9 — 1,487 Household Cleaning — — 21,691 21,691 Total segment revenues $ 172,080 $ 15,804 $ 21,691 $ 209,575 Three Months Ended June 30, 2015 (In thousands) North American OTC International OTC Household Consolidated Analgesics $ 26,848 $ 530 $ — $ 27,378 Cough & Cold 19,759 4,506 — 24,265 Women's Health 32,908 700 — 33,608 Gastrointestinal 20,320 3,808 — 24,128 Eye & Ear Care 24,307 3,955 — 28,262 Dermatologicals 20,095 534 — 20,629 Oral Care 9,977 194 — 10,171 Other OTC 1,412 7 — 1,419 Household Cleaning — — 22,272 22,272 Total segment revenues $ 155,626 $ 14,234 $ 22,272 $ 192,132
Allocation of Long-Term Assets to Segments	These consolidated goodwill and intangible assets have been allocated to the reportable segments as follows: June 30, 2016 (In thousands) North American OTC International OTC Household Cleaning Consolidated Goodwill $ 327,695 $ 22,030 $ 6,800 $ 356,525 Intangible assets Indefinite-lived 1,786,666 83,356 110,272 1,980,294 Finite-lived 219,570 1,453 22,242 243,265 Intangible assets, net 2,006,236 84,809 132,514 2,223,559 Total $ 2,333,931 $ 106,839 $ 139,314 $ 2,580,084 March 31, 2016 (In thousands) North American OTC International OTC Household Consolidated Goodwill $ 330,615 $ 22,776 $ 6,800 $ 360,191 Intangible assets Indefinite-lived 1,823,873 85,901 110,272 2,020,046 Finite-lived 277,762 2,237 22,678 302,677 Intangible assets, net 2,101,635 88,138 132,950 2,322,723 Total $ 2,432,250 $ 110,914 $ 139,750 $ 2,682,914

Condensed Consolidating Finan44

Condensed Consolidating Financial Statements (Tables)	3 Months Ended
	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidating Statements of Income and Comprehensive Income	Condensed Consolidating Statements of Operations and Comprehensive Income Three Months Ended June 30, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Brands, Inc., the issuer Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Revenues Net sales $ — $ 27,959 $ 168,205 $ 13,826 $ (1,220 ) $ 208,770 Other revenues — 75 801 486 (557 ) 805 Total revenues — 28,034 169,006 14,312 (1,777 ) 209,575 Cost of Sales Cost of sales (exclusive of depreciation shown below) — 12,086 71,462 6,000 (1,564 ) 87,984 Gross profit — 15,948 97,544 8,312 (213 ) 121,591 Operating Expenses Advertising and promotion — 4,745 20,804 2,086 — 27,635 General and administrative 1,937 2,188 14,314 1,018 — 19,457 Depreciation and amortization 920 151 5,633 128 — 6,832 Loss on sale of assets — — 55,453 — — 55,453 Total operating expenses 2,857 7,084 96,204 3,232 — 109,377 Operating income (loss) (2,857 ) 8,864 1,340 5,080 (213 ) 12,214 Other (income) expense Interest income (11,967 ) (21,262 ) (1,274 ) (159 ) 34,605 (57 ) Interest expense 8,440 21,174 24,901 1,274 (34,605 ) 21,184 Equity in (income) loss of subsidiaries 5,738 (31,333 ) (3,076 ) — 28,671 — Total other expense (income) 2,211 (31,421 ) 20,551 1,115 28,671 21,127 (Loss) income before income taxes (5,068 ) 40,285 (19,211 ) 3,965 (28,884 ) (8,913 ) (Benefit) provision for income taxes 463 3,178 (7,912 ) 889 — (3,382 ) Net (loss) income $ (5,531 ) $ 37,107 $ (11,299 ) $ 3,076 $ (28,884 ) $ (5,531 ) Comprehensive (loss) income, net of tax: Currency translation adjustments (5,824 ) (5,824 ) (5,824 ) (5,824 ) 17,472 (5,824 ) Total other comprehensive (loss) income (5,824 ) (5,824 ) (5,824 ) (5,824 ) 17,472 (5,824 ) Comprehensive (loss) income $ (11,355 ) $ 31,283 $ (17,123 ) $ (2,748 ) $ (11,412 ) $ (11,355 ) Condensed Consolidating Statements of Income and Comprehensive Income Three Months Ended June 30, 2015 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Revenues Net sales $ — $ 27,883 $ 152,524 $ 11,608 $ (728 ) $ 191,287 Other revenues — 96 819 498 (568 ) 845 Total revenues — 27,979 153,343 12,106 (1,296 ) 192,132 Cost of Sales Cost of sales (exclusive of depreciation shown below) — 10,441 66,378 4,408 (1,331 ) 79,896 Gross profit — 17,538 86,965 7,698 35 112,236 Operating Expenses Advertising and promotion — 2,517 21,228 2,677 — 26,422 General and administrative 1,315 2,555 11,951 1,768 — 17,589 Depreciation and amortization 989 146 4,445 140 — 5,720 Total operating expenses 2,304 5,218 37,624 4,585 — 49,731 Operating income (loss) (2,304 ) 12,320 49,341 3,113 35 62,505 Other (income) expense Interest income (12,049 ) (21,408 ) (1,220 ) (112 ) 34,762 (27 ) Interest expense 8,490 21,908 25,055 1,220 (34,762 ) 21,911 Loss on extinguishment of debt — 451 — — — 451 Equity in (income) loss of subsidiaries (25,306 ) (16,955 ) (1,450 ) — 43,711 — Total other (income) expense (28,865 ) (16,004 ) 22,385 1,108 43,711 22,335 Income (loss) before income taxes 26,561 28,324 26,956 2,005 (43,676 ) 40,170 Provision for income taxes 388 4,025 9,029 555 — 13,997 Net income (loss) $ 26,173 $ 24,299 $ 17,927 $ 1,450 $ (43,676 ) $ 26,173 Comprehensive income, net of tax: Currency translation adjustments (405 ) (405 ) (405 ) (405 ) 1,215 (405 ) Total other comprehensive income (loss) (405 ) (405 ) (405 ) (405 ) 1,215 (405 ) Comprehensive income (loss) $ 25,768 $ 23,894 $ 17,522 $ 1,045 $ (42,461 ) $ 25,768
Condensed Consolidating Balance Sheet	Condensed Consolidating Balance Sheet June 30, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 5,311 $ — $ 2,278 $ 21,288 $ — $ 28,877 Accounts receivable, net — 10,167 69,646 8,624 — 88,437 Inventories — 10,017 73,711 9,884 (745 ) 92,867 Deferred income tax assets 325 826 8,812 739 — 10,702 Prepaid expenses and other current assets 9,012 538 8,365 815 — 18,730 Assets held for sale — — 41,745 — — 41,745 Total current assets 14,648 21,548 204,557 41,350 (745 ) 281,358 Property and equipment, net 8,624 216 5,641 599 — 15,080 Goodwill — 66,007 268,490 22,028 — 356,525 Intangible assets, net — 191,655 1,946,309 85,595 — 2,223,559 Other long-term assets — 1,918 — — — 1,918 Intercompany receivables 1,460,733 2,664,832 1,249,875 11,046 (5,386,486 ) — Investment in subsidiary 1,631,033 1,553,227 77,679 — (3,261,939 ) — Total Assets $ 3,115,038 $ 4,499,403 $ 3,752,551 $ 160,618 $ (8,649,170 ) $ 2,878,440 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 1,384 $ 6,922 $ 24,731 $ 1,975 $ — $ 35,012 Accrued interest payable — 9,216 — — — 9,216 Other accrued liabilities 7,991 2,137 39,617 6,168 — 55,913 Total current liabilities 9,375 18,275 64,348 8,143 — 100,141 Long-term debt Principal amount — 1,602,500 — — — 1,602,500 Less unamortized debt costs — (25,086 ) — — — (25,086 ) Long-term debt, net — 1,577,414 — — — 1,577,414 Deferred income tax liabilities — 60,847 399,323 387 — 460,557 Other long-term liabilities — — 2,682 165 — 2,847 Intercompany payables 2,368,182 1,243,701 1,697,409 77,194 (5,386,486 ) — Total Liabilities 2,377,557 2,900,237 2,163,762 85,889 (5,386,486 ) 2,140,959 Stockholders' Equity Common stock 532 — — — — 532 Additional paid-in capital 451,075 1,280,947 1,359,921 78,774 (2,719,642 ) 451,075 Treasury stock, at cost (6,558 ) — — — — (6,558 ) Accumulated other comprehensive (loss) income, net of tax (29,349 ) (29,349 ) (29,349 ) (29,349 ) 88,047 (29,349 ) Retained earnings (accumulated deficit) 321,781 347,568 258,217 25,304 (631,089 ) 321,781 Total Stockholders' Equity 737,481 1,599,166 1,588,789 74,729 (3,262,684 ) 737,481 Total Liabilities and Stockholders' Equity $ 3,115,038 $ 4,499,403 $ 3,752,551 $ 160,618 $ (8,649,170 ) $ 2,878,440 Condensed Consolidating Balance Sheet March 31, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Assets Current assets Cash and cash equivalents $ 4,440 $ — $ 2,899 $ 19,891 $ — $ 27,230 Accounts receivable, net — 12,025 74,446 8,776 — 95,247 Inventories — 9,411 72,296 10,088 (532 ) 91,263 Deferred income tax assets 316 681 8,293 818 — 10,108 Prepaid expenses and other current assets 15,311 257 8,379 1,218 — 25,165 Total current assets 20,067 22,374 166,313 40,791 (532 ) 249,013 Property and equipment, net 9,166 210 5,528 636 — 15,540 Goodwill — 66,007 271,409 22,775 — 360,191 Intangible assets, net — 191,789 2,042,640 88,294 — 2,322,723 Other long-term assets — 1,324 — — — 1,324 Intercompany receivables 1,457,011 2,703,192 1,083,488 10,738 (5,254,429 ) — Investment in subsidiary 1,641,477 1,527,718 81,545 — (3,250,740 ) — Total Assets $ 3,127,721 $ 4,512,614 $ 3,650,923 $ 163,234 $ (8,505,701 ) $ 2,948,791 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 2,914 $ 7,643 $ 24,437 $ 3,302 $ — $ 38,296 Accrued interest payable — 8,664 — — — 8,664 Other accrued liabilities 12,285 1,714 38,734 6,991 — 59,724 Total current liabilities 15,199 18,021 63,171 10,293 — 106,684 Long-term debt Principal amount — 1,652,500 — — — 1,652,500 Less unamortized debt costs — (27,191 ) — — — (27,191 ) Long-term debt, net — 1,625,309 — — — 1,625,309 Deferred income tax liabilities — 60,317 408,893 412 — 469,622 Other long-term liabilities — — 2,682 158 — 2,840 Intercompany payables 2,368,186 1,241,084 1,570,265 74,894 (5,254,429 ) — Total Liabilities 2,383,385 2,944,731 2,045,011 85,757 (5,254,429 ) 2,204,455 Stockholders' Equity Common stock 530 — — — — 530 Additional paid-in capital 445,182 1,280,947 1,359,921 78,774 (2,719,642 ) 445,182 Treasury stock, at cost (5,163 ) — — — — (5,163 ) Accumulated other comprehensive income (loss), net of tax (23,525 ) (23,525 ) (23,525 ) (23,525 ) 70,575 (23,525 ) Retained earnings (accumulated deficit) 327,312 310,461 269,516 22,228 (602,205 ) 327,312 Total Stockholders' Equity 744,336 1,567,883 1,605,912 77,477 (3,251,272 ) 744,336 Total Liabilities and Stockholders' Equity $ 3,127,721 $ 4,512,614 $ 3,650,923 $ 163,234 $ (8,505,701 ) $ 2,948,791
Condensed Consolidating Statement of Cash Flows	Condensed Consolidating Statement of Cash Flows Three Months Ended June 30, 2016 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non- Guarantor Subsidiaries Eliminations Consolidated Operating Activities Net (loss) income $ (5,531 ) $ 37,107 $ (11,299 ) $ 3,076 $ (28,884 ) $ (5,531 ) Adjustments to reconcile net (loss) income to net cash provided by operating activities: Depreciation and amortization 920 151 5,633 128 — 6,832 Loss on sale of assets — — 55,453 — — 55,453 Deferred income taxes (9 ) 385 (10,089 ) 53 — (9,660 ) Amortization of debt origination costs — 2,231 — — — 2,231 Stock-based compensation costs 1,940 — — — — 1,940 Equity in income of subsidiaries 5,738 (31,333 ) (3,076 ) — 28,671 — Changes in operating assets and liabilities, net of effects from acquisitions: Accounts receivable — 1,858 4,800 (1,507 ) — 5,151 Inventories — (606 ) (3,835 ) (99 ) 213 (4,327 ) Prepaid expenses and other current assets 6,299 (281 ) (697 ) 376 — 5,697 Accounts payable (1,556 ) (721 ) 109 (1,233 ) — (3,401 ) Accrued liabilities (4,294 ) 975 261 (576 ) — (3,634 ) Net cash provided by operating activities 3,507 9,766 37,260 218 — 50,751 Investing Activities Purchases of property and equipment (225 ) (23 ) (596 ) (51 ) — (895 ) Net cash used in investing activities (225 ) (23 ) (596 ) (51 ) — (895 ) Financing Activities Term loan repayments — (50,000 ) — — — (50,000 ) Payments of debt origination costs — (9 ) — — — (9 ) Proceeds from exercise of stock options 3,405 — — — — 3,405 Excess tax benefits from share-based awards 550 — — — — 550 Fair value of shares surrendered as payment of tax withholding (1,395 ) — — — — (1,395 ) Intercompany activity, net (4,971 ) 40,266 (37,285 ) 1,990 — — Net cash (used in) provided by financing activities (2,411 ) (9,743 ) (37,285 ) 1,990 — (47,449 ) Effect of exchange rate changes on cash and cash equivalents — — — (760 ) — (760 ) Increase (decrease) in cash and cash equivalents 871 — (621 ) 1,397 — 1,647 Cash and cash equivalents - beginning of period 4,440 — 2,899 19,891 — 27,230 Cash and cash equivalents - end of period $ 5,311 $ — $ 2,278 $ 21,288 $ — $ 28,877 Condensed Consolidating Statement of Cash Flows Three Months Ended June 30, 2015 (In thousands) Prestige Brands Holdings, Inc. Prestige Combined Subsidiary Guarantors Combined Non-Guarantor Subsidiaries Eliminations Consolidated Operating Activities Net income (loss) $ 26,173 $ 24,299 $ 17,927 $ 1,450 $ (43,676 ) $ 26,173 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization 989 146 4,445 140 — 5,720 Gain on sale of asset — — — (36 ) — (36 ) Deferred income taxes 141 395 10,866 134 — 11,536 Amortization of debt origination costs — 2,138 — — — 2,138 Stock-based compensation costs 3,047 — — — — 3,047 Loss on extinguishment of debt — 451 — — — 451 Equity in income of subsidiaries (25,306 ) (16,955 ) (1,450 ) — 43,711 — Changes in operating assets and liabilities, net of effects from acquisitions: Accounts receivable — 3,171 735 (1,328 ) — 2,578 Inventories — 1,175 (1,457 ) 106 (35 ) (211 ) Prepaid expenses and other current assets (2,152 ) (102 ) 722 10 — (1,522 ) Accounts payable 861 (325 ) 880 (633 ) — 783 Accrued liabilities (5,668 ) (2,368 ) 975 (75 ) — (7,136 ) Net cash provided by (used in) operating activities (1,915 ) 12,025 33,643 (232 ) — 43,521 Investing Activities Purchases of property and equipment (648 ) — (27 ) (105 ) — (780 ) Proceeds from the sale of property and equipment — — — 344 — 344 Net cash (used in) provided by investing activities (648 ) — (27 ) 239 — (436 ) Financing Activities Term loan repayments — (25,000 ) — — — (25,000 ) Borrowings under revolving credit agreement — 15,000 — — — 15,000 Repayments under revolving credit agreement — (35,000 ) — — — (35,000 ) Payments of debt origination costs — (4,172 ) — — — (4,172 ) Proceeds from exercise of stock options 6,328 — — — — 6,328 Proceeds from restricted stock exercises 544 — — — — 544 Excess tax benefits from share-based awards 1,600 — — — — 1,600 Fair value of shares surrendered as payment of tax withholding (2,187 ) — — — — (2,187 ) Intercompany activity, net (4,277 ) 37,147 (33,616 ) 746 — — Net cash (used in) provided by financing activities 2,008 (12,025 ) (33,616 ) 746 — (42,887 ) Effect of exchange rate changes on cash and cash equivalents — — — 82 — 82 Increase (decrease) in cash and cash equivalents (555 ) — — 835 — 280 Cash and cash equivalents - beginning of period 11,387 — — 9,931 — 21,318 Cash and cash equivalents - end of period $ 10,832 $ — $ — $ 10,766 $ — $ 21,598

Business and Basis of Present45

Business and Basis of Presentation (Other Balance Sheet and Income Statement Items) (Details) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Ownership percentage, subsidiaries	100.00%
Term of original maturities, cash equivalents, up to and including	3 months
Shipping, warehousing and handling costs	$ 10.5	$ 8.7

Business and Basis of Present46

Business and Basis of Presentation (Property and Equipment) (Details)	3 Months Ended
	Jun. 30, 2016
Machinery
Property, Plant and Equipment [Line Items]
Property and equipment, useful lives	5 years
Computer equipment and software
Property, Plant and Equipment [Line Items]
Property and equipment, useful lives	3 years
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, useful lives	7 years

Business and Basis of Present47

Business and Basis of Presentation (Intangible Assets) (Details)	3 Months Ended
	Jun. 30, 2016
Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful lives	10 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful lives	30 years

Acquisitions (Narrative) (Detai

Acquisitions (Narrative) (Details) - USD ($) $ in Thousands	Feb. 05, 2016	Jun. 30, 2016	Mar. 31, 2016
Business Acquisition [Line Items]
Goodwill		$ 356,525	$ 360,191
DenTek Oral Care, Inc.
Business Acquisition [Line Items]
Purchase price	$ 228,300
Non-amortizable intangible assets	179,800
Amortizable intangible assets	$ 26,900
Purchased amortizable intangible assets, weighted average useful life	18 years 6 months
Purchased amortizable intangible assets, weighted average remaining period		18 years 2 months 12 days
Goodwill	$ 76,529

Acquisitions (Allocation of Ass

Acquisitions (Allocation of Assets Acquired and Liabilities Assumed) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016	Feb. 05, 2016
Purchase Price
Goodwill	$ 356,525	$ 360,191
DenTek Oral Care, Inc.
Purchase Price
Cash acquired			$ 1,359
Accounts receivable			9,187
Inventories			14,304
Deferred income taxes			3,303
Prepaids and other current assets			6,728
Property, plant and equipment, net			3,555
Goodwill			76,529
Intangible assets, net			206,700
Total assets acquired			321,665
Accounts payable			3,261
Accrued expenses			16,488
Deferred income tax liabilities - long term			73,573
Total liabilities assumed			93,322
Total purchase price			$ 228,343

Assets Held for Sale (Schedule

Assets Held for Sale (Schedule of Total Assets Held for Sale) (Details) - USD ($) $ in Thousands	Jul. 07, 2016	Jun. 30, 2016	Jun. 29, 2016	Jun. 30, 2016	Jun. 30, 2015	Mar. 31, 2016
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale		$ 41,745		$ 41,745		$ 0
Loss on sale of assets				55,453	$ 0
Disposal Group, Held-for-sale, Not Discontinued Operations | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | North American OTC Healthcare | Pediacare, New Skin and Fiber Choice
Long Lived Assets Held-for-sale [Line Items]
Loss on sale of assets		(55,500)
Inventory		2,420		2,420
Intangible assets, net		36,405		36,405
Goodwill		2,920		2,920
Assets held for sale		$ 41,745		$ 41,745
Disposal Group, Held-for-sale, Not Discontinued Operations | Pediacare | Cough & Cold | North American OTC Healthcare | Pediacare, New Skin and Fiber Choice
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale			$ 24,100
Disposal Group, Held-for-sale, Not Discontinued Operations | New Skin | Dermatologicals | North American OTC Healthcare | Pediacare, New Skin and Fiber Choice
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale			30,600
Disposal Group, Held-for-sale, Not Discontinued Operations | Fiber Choice | Gastrointestinal | North American OTC Healthcare | Pediacare, New Skin and Fiber Choice
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale			$ 11,400
Disposed of by Sale | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | North American OTC Healthcare | Pediacare, New Skin and Fiber Choice
Long Lived Assets Held-for-sale [Line Items]
Conditional services period			6 months
Subsequent Event | Disposed of by Sale | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | North American OTC Healthcare | Pediacare, New Skin and Fiber Choice
Long Lived Assets Held-for-sale [Line Items]
Purchase price	$ 40,000

Accounts Receivable (Component

Accounts Receivable (Components of Accounts Receivable) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 99,559	$ 106,853
Less allowances for discounts, returns and uncollectible accounts	(11,122)	(11,606)
Accounts receivable, net	88,437	95,247
Trade accounts receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	98,513	105,592
Other receivables
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable, gross	$ 1,046	$ 1,261

Inventories (Components of Inv

Inventories (Components of Inventories) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016
Inventory Disclosure [Abstract]
Packaging and raw materials	$ 7,442	$ 7,563
Finished goods	85,425	83,700
Inventories	92,867	91,263
Inventory valuation reserves related to obsolete and slow-moving inventory	$ 5,200	$ 4,800

Property and Equipment (Compon

Property and Equipment (Components of Property and Equipment) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Mar. 31, 2016
Components of Property and Equipment
Property and equipment, gross	$ 31,426		$ 30,361
Accumulated depreciation	(16,346)		(14,821)
Property and equipment, net	15,080		15,540
Depreciation expense	1,500	$ 1,300
Machinery
Components of Property and Equipment
Property and equipment, gross	8,444		7,734
Computer equipment
Components of Property and Equipment
Property and equipment, gross	13,154		12,793
Furniture and fixtures
Components of Property and Equipment
Property and equipment, gross	2,444		2,445
Leasehold improvements
Components of Property and Equipment
Property and equipment, gross	$ 7,384		$ 7,389

Goodwill (Schedule of Segment G

Goodwill (Schedule of Segment Goodwill) (Details) $ in Thousands	3 Months Ended
	Jun. 30, 2016USD ($)
Goodwill [Roll Forward]
Balance — March 31, 2016	$ 360,191
Reclassified to assets held for sale	(2,920)
Effects of foreign currency exchange rates	(746)
Balance — June 30, 2016	356,525
North American OTC Healthcare
Goodwill [Roll Forward]
Balance — March 31, 2016	330,615
Reclassified to assets held for sale	(2,920)
Effects of foreign currency exchange rates	0
Balance — June 30, 2016	327,695
International OTC Healthcare
Goodwill [Roll Forward]
Balance — March 31, 2016	22,776
Reclassified to assets held for sale	0
Effects of foreign currency exchange rates	(746)
Balance — June 30, 2016	22,030
Household Cleaning
Goodwill [Roll Forward]
Balance — March 31, 2016	6,800
Reclassified to assets held for sale	0
Effects of foreign currency exchange rates	0
Balance — June 30, 2016	$ 6,800

Goodwill (Narrative) (Details)

Goodwill (Narrative) (Details) - USD ($)	12 Months Ended
	Mar. 31, 2016	Jun. 30, 2016	Feb. 05, 2016
Goodwill [Line Items]
Goodwill	$ 360,191,000	$ 356,525,000
Goodwill impairment	$ 0
DenTek Oral Care, Inc.
Goodwill [Line Items]
Goodwill			$ 76,529,000

Intangible Assets (Schedule of

Intangible Assets (Schedule of Reconciliation of Activity Affecting Intangible Assets) (Details) $ in Thousands	3 Months Ended
	Jun. 30, 2016USD ($)	Mar. 31, 2016USD ($)
Indefinite-Lived Intangible Assets [Abstract]
Indefinite Lived Trademarks, beginning balance	$ 2,020,046
Indefinite Lived Trademarks, ending balance	1,980,294
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Finite Lived Trademarks, accumulated amortization, beginning balance	115,203
Accumulated amortization, reclassified to assets held for sale	(6,102)
Accumulated amortization, additions	5,313
Accumulated amortization, effects of foreign exchange rates	(9)
Finite Lived Trademarks, accumulated amortization, ending balance	114,405
Intangible Assets, Gross [Abstract]
Totals, gross, beginning balance	2,437,926
Totals, reclassified to assets held for sale	(97,310)
Totals, effects of foreign currency exchange rate	(2,652)
Totals, gross, ending balance	2,337,964
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets, net	243,265	$ 302,677
Intangible Assets, Net [Abstract]
Intangible assets, net	2,223,559	2,322,723
North American OTC Healthcare
Intangible Assets, Net [Abstract]
Intangible assets, net	2,006,236	2,101,635
International OTC Healthcare
Intangible Assets, Net [Abstract]
Intangible assets, net	84,809	88,138
Household Cleaning
Intangible Assets, Net [Abstract]
Intangible assets, net	132,514	132,950
Finite Lived Trademarks and Customer Relationships
Finite-Lived Intangible Assets, Gross [Abstract]
Finite Lived Trademarks and Customer Relationships, beginning balance	417,880
Finite-Lived Trademarks and Customer Relationships, reclassified to assets held for sale	(60,103)
Finite Lived Trademarks and Customer Relationships, effects of foreign currency exchange rate	(107)
Finite Lived Trademarks and Customer Relationships, ending balance	357,670
Finite-lived Intangible Assets, Accumulated Amortization [Abstract]
Finite Lived Trademarks, accumulated amortization, beginning balance	115,203
Accumulated amortization, reclassified to assets held for sale	(6,102)
Accumulated amortization, additions	5,313
Accumulated amortization, effects of foreign exchange rates	(9)
Finite Lived Trademarks, accumulated amortization, ending balance	114,405
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets, net	243,265
Finite Lived Trademarks and Customer Relationships | North American OTC Healthcare
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets, net	219,570	277,762
Finite Lived Trademarks and Customer Relationships | International OTC Healthcare
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets, net	1,453	2,237
Finite Lived Trademarks and Customer Relationships | Household Cleaning
Finite-Lived Intangible Assets, Net [Abstract]
Intangible assets, net	22,242	$ 22,678
Indefinite Lived Trademarks
Indefinite-Lived Intangible Assets [Abstract]
Indefinite Lived Trademarks, beginning balance	2,020,046
Indefinite-Lived Trademarks, reclassified to assets held for sale	(37,207)
Indefinite Lived Trademarks, effects of foreign currency exchange rate	(2,545)
Indefinite Lived Trademarks, ending balance	1,980,294
Indefinite Lived Trademarks | North American OTC Healthcare
Indefinite-Lived Intangible Assets [Abstract]
Indefinite Lived Trademarks, beginning balance	1,823,873
Indefinite Lived Trademarks, ending balance	1,786,666
Indefinite Lived Trademarks | International OTC Healthcare
Indefinite-Lived Intangible Assets [Abstract]
Indefinite Lived Trademarks, beginning balance	85,901
Indefinite Lived Trademarks, ending balance	83,356
Indefinite Lived Trademarks | Household Cleaning
Indefinite-Lived Intangible Assets [Abstract]
Indefinite Lived Trademarks, beginning balance	110,272
Indefinite Lived Trademarks, ending balance	$ 110,272

Intangible Assets (Narrative) (

Intangible Assets (Narrative) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Jun. 30, 2016	Jun. 30, 2015	Feb. 05, 2016
Finite-Lived Intangible Assets [Line Items]
Loss on sale of assets		$ 55,453	$ 0
Purchased amortizable intangible assets, weighted average remaining period		13 years 4 months 24 days
Amortization expense		$ 5,313
Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful lives		10 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible assets, useful lives		30 years
DenTek Oral Care, Inc.
Finite-Lived Intangible Assets [Line Items]
Intangible assets, net				$ 206,700
Intangible assets, useful lives		18 years 2 months 12 days
Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | Pediacare, New Skin and Fiber Choice | North American OTC Healthcare | Disposal Group, Held-for-sale, Not Discontinued Operations
Finite-Lived Intangible Assets [Line Items]
Loss on sale of assets	$ (55,500)
Indefinite-lived intangible assets, reclassified to assets held for sale	37,200
Finite-lived intangible assets, reclassified to assets held for sale	$ 54,000

Intangible Assets (Expected Amo

Intangible Assets (Expected Amortization Expense) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2017 (Remaining nine months ending March 31, 2017)	$ 13,654
2,018	18,049
2,019	18,049
2,020	18,049
2,021	17,626
Thereafter	157,838
Intangible assets, net	$ 243,265	$ 302,677

Other Accrued Liabilities (Summ

Other Accrued Liabilities (Summary of Accrued Liabilities and Accounts Payable) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016
Payables and Accruals [Abstract]
Accrued marketing costs	$ 29,410	$ 26,373
Accrued compensation costs	4,275	9,574
Accrued broker commissions	564	1,497
Income taxes payable	3,282	3,675
Accrued professional fees	2,226	1,787
Deferred rent	747	836
Accrued production costs	3,413	3,324
Accrued lease termination costs	417	448
Income tax related payable	6,354	6,354
Other accrued liabilities	5,225	5,856
Total other accrued liabilities	$ 55,913	$ 59,724

Long-Term Debt (2012 Term Loan

Long-Term Debt (2012 Term Loan and 2012 ABL Revolver) (Details) - USD ($)	Feb. 04, 2016	Jun. 09, 2015	Sep. 03, 2014	Feb. 21, 2013	Jan. 31, 2012	Jun. 30, 2016	Jun. 30, 2015	Mar. 31, 2013	Mar. 31, 2015	Mar. 31, 2016	May 08, 2015
Debt Instrument [Line Items]
Loss on extinguishment of debt						$ 0	$ 451,000
Term Loan and ABL Revolver 2012
Debt Instrument [Line Items]
Debt issuance costs capitalized					$ 20,600,000
2012 ABL Revolver | Revolving Credit Facility
Debt Instrument [Line Items]
Debt instrument, maturity term					5 years
Line of credit facility, maximum borrowing capacity					$ 50,000,000	135,000,000
Line of credit facility, increase in borrowing capacity						$ 85,000,000
Debt instrument, interest rate, increase/(decrease) (percent)									(0.25%)
Line of credit facility, commitment fee percentage					0.50%
Line of credit facility, conditional commitment fee percentage						0.375%
Line of credit facility, increase in accordion feature		$ 35,000,000
Long-term debt, weighted average interest rate						2.20%
2012 ABL Revolver | Revolving Credit Facility | LIBOR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate, fixed component (percent)			1.00%
2012 ABL Revolver | Revolving Credit Facility | LIBOR | Minimum
Debt Instrument [Line Items]
Debt instrument, conditional variable rate (percent)			2.00%
2012 ABL Revolver | Revolving Credit Facility | LIBOR | Maximum
Debt Instrument [Line Items]
Debt instrument, conditional variable rate (percent)			2.25%
2012 ABL Revolver | Revolving Credit Facility | Base Rate | Minimum
Debt Instrument [Line Items]
Debt instrument, conditional variable rate (percent)			1.00%
2012 ABL Revolver | Revolving Credit Facility | Base Rate | Maximum
Debt Instrument [Line Items]
Debt instrument, conditional variable rate (percent)			1.25%
2012 ABL Revolver | Revolving Credit Facility | Federal Funds Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate, fixed component (percent)			0.50%
2012 ABL Revolver Amendment 3 | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, increase in borrowing capacity			$ 40,000,000
2012 ABL Revolver Amendment 5 | Revolving Credit Facility
Debt Instrument [Line Items]
Temporary suspension of financial reporting covenant, period	60 days
Senior Notes | 2012 Senior Notes
Debt Instrument [Line Items]
Debt instrument, face amount					$ 660,000,000
Debt instrument, stated interest rate (percent)				8.125%		0.00%				8.125%
Term Loans | 2012 Term Loan
Debt Instrument [Line Items]
Debt instrument, maturity term					7 years
Debt instrument, discount, percentage					1.50%
Proceeds from issuance of long-term debt					$ 650,100,000
Term Loans | Amendment 1, 2012 Term Loan
Debt Instrument [Line Items]
Loss on extinguishment of debt								$ 1,400,000
Term Loans | Amendment 1, 2012 Term Loan | LIBOR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate (percent)				2.75%
Debt instrument, reference rate floor (percent)				1.00%
Term Loans | Amendment 1, 2012 Term Loan | Base Rate
Debt Instrument [Line Items]
Debt instrument, reference rate floor (percent)				2.00%
Term Loans | Amendment 2, 2012 Term Loan
Debt Instrument [Line Items]
Debt instrument, reference rate floor (percent)			1.00%
Term Loans | Amendment 2, 2012 Term Loan | LIBOR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate (percent)			3.125%
Term Loans | Amendment 2, 2012 Term Loan | Base Rate
Debt Instrument [Line Items]
Debt instrument, reference rate floor (percent)			2.00%
Term Loans | Amendment 3, 2012 Term Loan
Debt Instrument [Line Items]
Debt instrument, average interest rate during period (percent)						4.70%
Debt instrument, quarterly payment, percent of original principal amount (percent)			0.25%
Term Loans | Amendment 3, 2012 Term Loan | LIBOR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate, fixed component (percent)			1.00%
Term Loans | Amendment 3, 2012 Term Loan | LIBOR | Minimum
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate (percent)			0.75%
Term Loans | Amendment 3, 2012 Term Loan | Base Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate, fixed component (percent)			1.75%
Term Loans | Amendment 3, 2012 Term Loan | Federal Funds Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate, fixed component (percent)			0.50%
Term B-2 | Amendment 2, 2012 Term Loan
Debt Instrument [Line Items]
Debt instrument, face amount			$ 720,000,000
Term B-2 | Amendment 2, 2012 Term Loan | LIBOR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate (percent)			3.50%
Debt instrument, reference rate floor (percent)			1.00%
Term B-2 | Amendment 2, 2012 Term Loan | Base Rate
Debt Instrument [Line Items]
Debt instrument, reference rate floor (percent)			2.00%
Debt instrument, step down interest rate (percent)			3.25%
Term B-2 | Amendment 3, 2012 Term Loan
Debt Instrument [Line Items]
Debt instrument, face amount											$ 645,000,000
Loans Payable, Term B-3 | 2012 Senior Notes | LIBOR
Debt Instrument [Line Items]
Debt instrument, reference rate floor (percent)						0.75%				0.75%
Loans Payable, Term B-3 | 2012 Senior Notes | Base Rate
Debt Instrument [Line Items]
Debt instrument, reference rate floor (percent)						1.75%				1.75%
Loans Payable, Term B-3 | Amendment 3, 2012 Term Loan
Debt Instrument [Line Items]
Debt instrument, face amount											852,500,000
Loans Payable, Term B-1 | Amendment 3, 2012 Term Loan
Debt Instrument [Line Items]
Debt instrument, face amount											$ 207,500,000

Long-Term Debt (Senior Notes) (

Long-Term Debt (Senior Notes) (Details) - Senior Notes - USD ($)	Jun. 30, 2016	Mar. 31, 2016	Feb. 19, 2016	Dec. 17, 2013
2016 Senior Notes
Debt Instrument [Line Items]
Debt instrument, face amount			$ 350,000,000
Debt instrument, stated interest rate (percent)	6.375%	6.375%	6.375%
Debt issuance costs capitalized			$ 5,500,000
2013 Senior Notes
Debt Instrument [Line Items]
Debt instrument, face amount				$ 400,000,000
Debt instrument, stated interest rate (percent)	0.00%	5.375%		5.375%
Debt issuance costs capitalized				$ 7,200,000

Long-Term Debt (Redemptions and

Long-Term Debt (Redemptions and Restrictions) (Details) - USD ($) $ in Millions	Feb. 19, 2016	Jun. 30, 2016	Mar. 31, 2016
Debt Instrument [Line Items]
Unamortized discount (premium) and debt issuance costs, net		$ 25.1	$ 27.2
2012 ABL Revolver | Revolving Credit Facility
Debt Instrument [Line Items]
Term loan repayments		85
Line of credit facility, remaining borrowing capacity		38.6
2012 ABL Revolver | Revolving Credit Facility | Other long-term assets
Debt Instrument [Line Items]
Unamortized debt costs related to 2012 ABL Revolver		$ 1.2	1.3
Senior Notes | 2013 Senior Notes
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage		101.00%
Unamortized discount (premium) and debt issuance costs, net		$ 5.2	5.4
Senior Notes | 2016 Senior Notes
Debt Instrument [Line Items]
Unamortized discount (premium) and debt issuance costs, net		5.3	5.4
Term Loans | 2012 Term Loan
Debt Instrument [Line Items]
Unamortized discount (premium) and debt issuance costs, net		$ 14.6	$ 16.4
Debt Instrument, Redemption, Period One | Senior Notes | 2013 Senior Notes
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage		100.00%
Redemption price, percentage of principal amount, using proceeds of equity offerings		105.375%
Debt Instrument, Redemption, Period Two | Senior Notes | 2016 Senior Notes
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage	100.00%
Maximum | Debt Instrument, Redemption, Period One | Senior Notes | 2013 Senior Notes
Debt Instrument [Line Items]
Redemption price, percentage of principal amount redeemed		35.00%
Maximum | Debt Instrument, Redemption, Period Two | Senior Notes | 2016 Senior Notes
Debt Instrument [Line Items]
Redemption price, percentage of principal amount redeemed	40.00%
Indirect Guarantee of Indebtedness | Senior Notes | 2016 Senior Notes
Debt Instrument [Line Items]
Debt instrument, redemption price, percentage	101.00%

Long-Term Debt (Schedule of Lon

Long-Term Debt (Schedule of Long-term Debt) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016	Feb. 19, 2016	Dec. 17, 2013	Feb. 21, 2013
Debt Instrument [Line Items]
Long-term debt, gross	$ 1,602,500	$ 1,652,500
Current portion of long-term debt	0	0
Principal amount	1,602,500	1,652,500
Less: unamortized debt costs	(25,086)	(27,191)
Long-term debt, net	1,577,414	1,625,309
2012 ABL Revolver | Revolving Credit Facility
Debt Instrument [Line Items]
Long-term debt, gross	$ 85,000	$ 85,000
Senior Notes | 2016 Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated interest rate (percent)	6.375%	6.375%	6.375%
Long-term debt, gross	$ 350,000	$ 350,000
Senior Notes | 2013 Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated interest rate (percent)	0.00%	5.375%		5.375%
Long-term debt, gross	$ 400,000	$ 400,000
Senior Notes | 2012 Senior Notes
Debt Instrument [Line Items]
Debt instrument, stated interest rate (percent)	0.00%	8.125%			8.125%
Loans Payable, Term B-3 | 2012 Senior Notes
Debt Instrument [Line Items]
Long-term debt, gross	$ 767,500	$ 817,500
Loans Payable, Term B-3 | 2012 Senior Notes | Base Rate
Debt Instrument [Line Items]
Debt instrument, reference rate floor (percent)	1.75%	1.75%
Loans Payable, Term B-3 | 2012 Senior Notes | LIBOR
Debt Instrument [Line Items]
Debt instrument, reference rate floor (percent)	0.75%	0.75%

Long-Term Debt (Maturities of L

Long-Term Debt (Maturities of Long-term Debt) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016
Debt Disclosure [Abstract]
2017 (remaining nine months ending March 31, 2017)	$ 0
2,018	0
2,019	0
2,020	0
2,021	85,000
Thereafter	1,517,500
Long-term debt, gross	$ 1,602,500	$ 1,652,500

Fair Value Measurements (Summa

Fair Value Measurements (Summary of Carrying Amounts and Estimated Fair Values) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016
Senior Notes | 2016 Senior Notes | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	$ 350,000	$ 350,000
Senior Notes | 2013 Senior Notes | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	400,000	400,000
Term B-3 Loans | 2012 Term Loan | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	767,500	817,500
Revolving Credit Facility | 2012 ABL Revolver
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
2012 ABL Revolver	85,000	85,000
Fair Value, Measurements, Recurring | Senior Notes | 2016 Senior Notes | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	359,625	363,125
Fair Value, Measurements, Recurring | Senior Notes | 2013 Senior Notes | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	404,000	408,000
Fair Value, Measurements, Recurring | Term B-3 Loans | 2012 Term Loan | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, senior notes and term loans	766,541	818,522
Fair Value, Measurements, Recurring | Revolving Credit Facility | 2012 ABL Revolver | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
2012 ABL Revolver	85,000	$ 85,000
North American OTC Healthcare | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | Disposal Group, Held-for-sale, Not Discontinued Operations | Pediacare, New Skin and Fiber Choice | Fair Value, Inputs, Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gain (loss) on disposal of assets held for sale	55,500
Gain (loss) on disposal of assets held for sale, after tax	$ 35,500

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details)	3 Months Ended
	Jun. 30, 2016USD ($)vote$ / sharesshares	Jun. 30, 2015$ / sharesshares	Mar. 31, 2016$ / sharesshares
Class of Stock [Line Items]
Common stock, shares authorized (shares) | shares	250,000,000		250,000,000
Common stock, par value (in USD per share) | $ / shares	$ 0.01		$ 0.01
Preferred stock, shares authorized (shares) | shares	5,000,000		5,000,000
Preferred stock, par value (in USD per share) | $ / shares	$ 0.01		$ 0.01
Voting rights, number of votes per common share owned | vote	1
Dividends declared on common stock | $	$ 0
Restricted Shares
Class of Stock [Line Items]
Restricted stock repurchased during period (shares) | shares	24,988	39,429
Restricted stock acquired, average cost per share (in USD per share) | $ / shares	$ 55.82	$ 41.66

Accumulated Other Comprehensi67

Accumulated Other Comprehensive Loss (Components of AOCI) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016
Stockholders' Equity Note [Abstract]
Cumulative translation adjustment	$ (29,349)	$ (23,525)
Accumulated other comprehensive loss, net of tax	$ (29,349)	$ (23,525)

(Computation of Basis and Dilut

(Computation of Basis and Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Numerator
Net (loss) income	$ (5,531)	$ 26,173
Denominator
Denominator for basic earnings per share — weighted average shares outstanding (in shares)	52,881	52,548
Dilutive effect of unvested restricted stock units and options issued to employees and directors (in shares)	0	410
Denominator for diluted earnings per share (in shares)	52,881	52,958
Earnings per Common Share:
Basic net earnings per share (in USD per share)	$ (0.10)	$ 0.50
Diluted net earnings per share (in USD per share)	$ (0.10)	$ 0.49

Earnings Per Share (Antidilutiv

Earnings Per Share (Antidilutive Securities) (Details) - shares shares in Millions	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Outstanding Stock Awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0.7	0.2

Share-Based Compensation (Narra

Share-Based Compensation (Narrative) (Details) $ / shares in Units, $ in Millions	May 26, 2016shares	May 09, 2016$ / sharesshares	Aug. 04, 2015shares	May 11, 2015shares	May 31, 2014shares	Jun. 30, 2014shares	Jun. 30, 2016USD ($)director$ / sharesshares	Jun. 30, 2015USD ($)$ / sharesshares
Share-based Compensation, Aggregate Disclosures:
Number of shares authorized for grant under 2005 Long-Term Equity Incentive Plan (in shares)							5,000,000
Share-based compensation costs charged against income | $							$ 1.9	$ 3
Tax benefit recognized from share-based compensation expense | $							$ 0.7	$ 1.1
Stock options granted (in shares)		224,843					224,800	186,300
Restricted Shares
Board of directors, number of directors | director							6
Options, Additional Disclosures:
Options granted, weighted-average grant-date fair value (in USD per share) | $ / shares							$ 22.26	$ 16.95
Options exercised, aggregate intrinsic value | $							$ 2.3
Unrecognized compensation costs related to nonvested awards | $							$ 13.8
Unrecognized compensation costs related to nonvested awards, weighted average period for recognition							1 year 1 month 15 days
Total fair value of vested shares | $							$ 7	$ 6.2
Cash received from exercise of stock options | $							3.4	6.3
Tax benefit realized from exercise of stock options | $							$ 0.7	$ 1
Shares available for issuance under the Plan (in shares)							2,400,000
Restricted Stock Units (RSUs)
Share-based Compensation, Aggregate Disclosures:
Granted in period to each independent director (in shares)		49,064	2,075				49,400	243,800
Award vesting period		3 years
Restricted Shares
Period following director's term in which RSUs may be settled			6 months
Granted, weighted-average grant-date fair value (in USD per share) | $ / shares							$ 57.16	$ 41.85
Stock Options
Share-based Compensation, Aggregate Disclosures:
Award vesting period		3 years
Annual award vesting percentage		33.30%
Expected term in years		10 years					6 years	6 years
Stock options granted, exercise price (in USD per share) | $ / shares		$ 57.18
Stock Options | Minimum
Share-based Compensation, Aggregate Disclosures:
Award vesting period							3 years
Stock Options | Maximum
Share-based Compensation, Aggregate Disclosures:
Award vesting period							5 years
Options, Additional Disclosures:
Award exercisability period, from date of grant							10 years
Restricted Shares
Restricted Shares
Granted, weighted-average grant-date fair value (in USD per share) | $ / shares							$ 57.16	$ 41.85
Restricted Shares | Minimum
Share-based Compensation, Aggregate Disclosures:
Award vesting period							3 years
Restricted Shares | Maximum
Share-based Compensation, Aggregate Disclosures:
Award vesting period							5 years
Employee | Restricted Shares
Share-based Compensation, Aggregate Disclosures:
Award vesting period							3 years
Director | Restricted Stock Units (RSUs)
Share-based Compensation, Aggregate Disclosures:
Granted in period to each independent director (in shares)	346			362
Restricted Shares
Number of common shares into which each RSU may be converted (in shares)			1
Director | Restricted Shares
Share-based Compensation, Aggregate Disclosures:
Award vesting period							1 year
2005 Long-Term Incentive Plan
Share-based Compensation, Aggregate Disclosures:
Number of additional shares authorized (in shares)						1,800,000
Maximum number of shares per participant, 12 month period (in shares)					1,000,000	2,500,000
Extension of plan term						10 years

Share-Based Compensation (Restr

Share-Based Compensation (Restricted Stock Units Activity) (Details) - Restricted Stock Units (RSUs) - $ / shares	May 09, 2016	Aug. 04, 2015	Jun. 30, 2016	Jun. 30, 2015
Shares
Outstanding, beginning of period (in shares)			467,800	362,300
Granted (in shares)	49,064	2,075	49,400	243,800
Vested and issued (in shares)			(75,600)	(138,900)
Forfeited (in shares)			(76,200)	(1,400)
Outstanding, end of period (in shares)			365,400	465,800
Vested, end of period (in shares)			70,200	76,600
Weighted- Average Grant-Date Fair Value
Outstanding, beginning of period, weighted-average grant-date fair value (in USD per share)			$ 35.22	$ 22.74
Granted, weighted-average grant-date fair value (in USD per share)			57.16	41.85
Vested and issued, weighted-average grant-date fair value (in USD per share)			31.36	19.35
Forfeited, weighted-average grant-date fair value (in USD per share)			39.93	33.50
Outstanding, end of period, weighted-average grant-date fair value (in USD per share)			38	33.72
Vested, end of period, weighted-average grant-date fair value (in USD per share)			$ 14.89	$ 11.62

Share-Based Compensation (Stock

Share-Based Compensation (Stock Option Valuation Assumptions) (Details) - Stock Options - USD ($)	May 09, 2016	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility		37.80%	40.20%
Expected dividends		$ 0	$ 0
Expected term in years	10 years	6 years	6 years
Risk-free rate		1.70%	1.70%

Share-Based Compensation (Sto73

Share-Based Compensation (Stock Option Activity) (Details) - USD ($) $ / shares in Units, $ in Thousands	May 09, 2016	Jun. 30, 2016	Jun. 30, 2015
Shares
Outstanding, beginning of period (in shares)		727,700	871,200
Granted (in shares)	224,843	224,800	186,300
Exercised (in shares)		(105,700)	(330,400)
Forfeited or expired (in shares)		(45,500)	(900)
Outstanding, end of period (in shares)		801,300	726,200
Exercisable, end of period (in shares)		386,400	322,500
Weighted- Average Exercise Price
Outstanding, beginning of period, weighted-average exercise price (in USD per share)		$ 30.70	$ 23.40
Granted, weighted-average exercise price (in USD per share)		57.18	41.44
Exercised, weighted-average exercise price (in USD per share)		32.20	19.15
Forfeited or expired, weighted-average exercise price (in USD per share)		37.34	33.50
Outstanding, end of period, weighted-average exercise price (in USD per share)		37.55	29.95
Exercisable, end of period, weighted-average exercise price (in USD per share)		$ 25.20	$ 21.54
Options, Additional Disclosures:
Outstanding, end of period, weighted-average remaining contractual term		8 years	8 years 3 months
Exercisable, end of period, weighted-average remaining contractual term		6 years 8 months 12 days	7 years 2 months
Outstanding, end of period, aggregate intrinsic value		$ 14,700	$ 11,830
Exercisable, end of period, aggregate intrinsic value		$ 11,669	$ 7,966

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Effective income tax rate (percent)	37.90%	34.80%
Realized deferred tax liabilities from sale of assets	$ (19.4)
Ownership percentage, subsidiaries	100.00%
Net operating loss carryforwards	$ 20.9
Deferred tax assets, operating loss carryforwards	7.4
Operating loss carryforwards, limitation on use, annual amount	33.6
Uncertain tax liability	$ 4.1		$ 4.1

Commitments and Contingencies75

Commitments and Contingencies (Future Minimum Rental Payments) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Mar. 31, 2016
Operating Leased Assets [Line Items]
2017 (Remaining nine months ending March 31, 2017)	$ 1,556
2,018	2,015
2,019	2,009
2,020	1,842
2,021	903
Thereafter	59
Total future minimum payments due	8,384		$ 8,434
Less: Sublease rentals	(1,100)		(1,165)
Minimum lease payments, less minimum sublease rentals	7,284		$ 7,269
Rent expense	600	$ 400
Facilities
Operating Leased Assets [Line Items]
2017 (Remaining nine months ending March 31, 2017)	1,522
2,018	2,015
2,019	2,009
2,020	1,842
2,021	903
Thereafter	59
Total future minimum payments due	8,350
Equipment
Operating Leased Assets [Line Items]
2017 (Remaining nine months ending March 31, 2017)	34
2,018	0
2,019	0
2,020	0
2,021	0
Thereafter	0
Total future minimum payments due	$ 34

Commitments and Contingencies76

Commitments and Contingencies (Long-term Supply Agreement) (Details) - Third-party Manufacturing - USD ($) $ in Thousands	Nov. 01, 2009	Jun. 30, 2016
Long-term Purchase Commitment [Line Items]
Supply agreement, term	10 years
2017 (Remaining nine months ending March 31, 2017)		$ 803
2,018		1,013
2,019		982
2,020		560
2,021		0
Total purchase commitment		$ 3,358

Concentrations of Risk (Narrati

Concentrations of Risk (Narrative) (Details)	3 Months Ended
	Jun. 30, 2016manufacturercustomer	Jun. 30, 2015manufacturer
Concentration Risk [Line Items]
Number of third-party manufacturers	102	98
Sales | Product Concentration Risk | Top 5 Customers
Concentration Risk [Line Items]
Concentration risk, percentage	42.30%	43.90%
Sales | Customer Concentration Risk | Walmart
Concentration Risk [Line Items]
Concentration risk, percentage	20.70%	19.90%
Number of customers exceeding concentration risk benchmark | customer	1
Sales | Customer Concentration Risk | Walgreens
Concentration Risk [Line Items]
Concentration risk, percentage	10.30%	9.40%
Sales | Supplier Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	79.70%	83.90%
Number of third-party manufacturers with long-term contracts	55	47
Accounts Receivable | Customer Concentration Risk | Walmart
Concentration Risk [Line Items]
Concentration risk, percentage	23.20%
Accounts Receivable | Customer Concentration Risk | Walgreens
Concentration Risk [Line Items]
Concentration risk, percentage	10.20%

Business Segments (Information

Business Segments (Information on Operating and Reportable Segments) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Jun. 30, 2016	Jun. 30, 2015
Segment Reporting Information, Profit (Loss):
Gross segment revenues		$ 208,770	$ 191,287
Other revenues		805	845
Total segment revenues		209,575	192,132
Cost of sales		87,984	79,896
Gross profit		121,591	112,236
Advertising and promotion		27,635	26,422
Contribution margin		93,956	85,814
Other operating expenses		81,742	23,309
Operating income		12,214	62,505
Other expense		21,127	22,335
Loss before income taxes		(8,913)	40,170
(Benefit) provision for income taxes		(3,382)	13,997
Net (loss) income		(5,531)	26,173
Loss on sale of assets		55,453	0
North American OTC Healthcare
Segment Reporting Information, Profit (Loss):
Gross segment revenues		172,080	155,611
International OTC Healthcare
Segment Reporting Information, Profit (Loss):
Gross segment revenues		15,800	14,209
Household Cleaning
Segment Reporting Information, Profit (Loss):
Gross segment revenues		20,890	21,467
Operating Segments
Segment Reporting Information, Profit (Loss):
Gross segment revenues		209,991	192,015
Operating Segments | North American OTC Healthcare
Segment Reporting Information, Profit (Loss):
Gross segment revenues		173,301	156,339
Other revenues		0	15
Total segment revenues		172,080	155,626
Cost of sales		65,718	58,503
Gross profit		106,362	97,123
Advertising and promotion		25,040	23,195
Contribution margin		81,322	73,928
Operating Segments | International OTC Healthcare
Segment Reporting Information, Profit (Loss):
Gross segment revenues		15,800	14,209
Other revenues		4	25
Total segment revenues		15,804	14,234
Cost of sales		5,464	4,913
Gross profit		10,340	9,321
Advertising and promotion		2,124	2,723
Contribution margin		8,216	6,598
Operating Segments | Household Cleaning
Segment Reporting Information, Profit (Loss):
Gross segment revenues		20,890	21,467
Other revenues		801	805
Total segment revenues		21,691	22,272
Cost of sales		16,802	16,480
Gross profit		4,889	5,792
Advertising and promotion		471	504
Contribution margin		4,418	5,288
Intersegment Eliminations
Segment Reporting Information, Profit (Loss):
Gross segment revenues		(1,221)	(728)
Intersegment Eliminations | North American OTC Healthcare
Segment Reporting Information, Profit (Loss):
Gross segment revenues		(1,221)	(728)
Intersegment Eliminations | International OTC Healthcare
Segment Reporting Information, Profit (Loss):
Gross segment revenues		0	0
Intersegment Eliminations | Household Cleaning
Segment Reporting Information, Profit (Loss):
Gross segment revenues		$ 0	$ 0
Pediacare, New Skin and Fiber Choice | Disposal Group, Held-for-sale, Not Discontinued Operations | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | North American OTC Healthcare
Segment Reporting Information, Profit (Loss):
Loss on sale of assets	$ (55,500)

Business Segments (Revenue by P

Business Segments (Revenue by Product) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	$ 209,575	$ 192,132
Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	28,653	27,378
Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	22,359	24,265
Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	33,823	33,608
Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	23,362	24,128
Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	28,803	28,262
Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	23,369	20,629
Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	26,028	10,171
Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	1,487	1,419
Household Cleaning
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	21,691	22,272
Operating Segments | North American OTC Healthcare
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	172,080	155,626
Operating Segments | North American OTC Healthcare | Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	28,126	26,848
Operating Segments | North American OTC Healthcare | Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	17,967	19,759
Operating Segments | North American OTC Healthcare | Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	32,887	32,908
Operating Segments | North American OTC Healthcare | Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	19,106	20,320
Operating Segments | North American OTC Healthcare | Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	26,007	24,307
Operating Segments | North American OTC Healthcare | Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	22,698	20,095
Operating Segments | North American OTC Healthcare | Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	23,811	9,977
Operating Segments | North American OTC Healthcare | Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	1,478	1,412
Operating Segments | International OTC Healthcare
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	15,804	14,234
Operating Segments | International OTC Healthcare | Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	527	530
Operating Segments | International OTC Healthcare | Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	4,392	4,506
Operating Segments | International OTC Healthcare | Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	936	700
Operating Segments | International OTC Healthcare | Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	4,256	3,808
Operating Segments | International OTC Healthcare | Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	2,796	3,955
Operating Segments | International OTC Healthcare | Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	671	534
Operating Segments | International OTC Healthcare | Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	2,217	194
Operating Segments | International OTC Healthcare | Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	9	7
Operating Segments | Household Cleaning
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	21,691	22,272
Operating Segments | Household Cleaning | Analgesics
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Operating Segments | Household Cleaning | Cough & Cold
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Operating Segments | Household Cleaning | Women's Health
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Operating Segments | Household Cleaning | Gastrointestinal
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Operating Segments | Household Cleaning | Eye & Ear Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Operating Segments | Household Cleaning | Dermatologicals
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Operating Segments | Household Cleaning | Oral Care
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Operating Segments | Household Cleaning | Other OTC
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	0	0
Operating Segments | Household Cleaning | Household Cleaning
Geographic Areas, Revenues from External Customers [Abstract]
Total segment revenues	$ 21,691	$ 22,272

Business Segments (Assets by Se

Business Segments (Assets by Segment) (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Jun. 30, 2016USD ($)customer	Jun. 30, 2015	Mar. 31, 2016USD ($)
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	$ 356,525		$ 360,191
Indefinite-lived	1,980,294		2,020,046
Finite-lived	243,265		302,677
Intangible assets, net	2,223,559		2,322,723
Intangible assets, net (including goodwill)	2,580,084		2,682,914
Finite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Finite-lived	243,265
Indefinite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Indefinite-lived	1,980,294		2,020,046
North American OTC Healthcare
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	327,695		330,615
Intangible assets, net	2,006,236		2,101,635
Intangible assets, net (including goodwill)	2,333,931		2,432,250
North American OTC Healthcare | Finite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Finite-lived	219,570		277,762
North American OTC Healthcare | Indefinite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Indefinite-lived	1,786,666		1,823,873
International OTC Healthcare
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	22,030		22,776
Intangible assets, net	84,809		88,138
Intangible assets, net (including goodwill)	106,839		110,914
International OTC Healthcare | Finite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Finite-lived	1,453		2,237
International OTC Healthcare | Indefinite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Indefinite-lived	83,356		85,901
Household Cleaning
Segment Reporting, Asset Reconciling Item [Line Items]
Goodwill	6,800		6,800
Intangible assets, net	132,514		132,950
Intangible assets, net (including goodwill)	139,314		139,750
Household Cleaning | Finite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Finite-lived	22,242		22,678
Household Cleaning | Indefinite Lived Intangibles
Segment Reporting, Asset Reconciling Item [Line Items]
Indefinite-lived	$ 110,272		$ 110,272
Sales | UNITED STATES | Geographic Concentration Risk
Segment Reporting, Asset Reconciling Item [Line Items]
Number of customers exceeding threshold | customer	0
Concentration risk, percentage	87.50%	87.30%
Sales | CANADA | Geographic Concentration Risk
Segment Reporting, Asset Reconciling Item [Line Items]
Concentration risk, percentage	4.70%	5.10%
Sales | AUSTRALIA | Geographic Concentration Risk
Segment Reporting, Asset Reconciling Item [Line Items]
Concentration risk, percentage	5.00%	5.70%
Goodwill and Intangible Assets | UNITED STATES | Geographic Concentration Risk
Segment Reporting, Asset Reconciling Item [Line Items]
Concentration risk, percentage	95.90%		95.90%
Goodwill and Intangible Assets | AUSTRALIA | Geographic Concentration Risk
Segment Reporting, Asset Reconciling Item [Line Items]
Concentration risk, percentage	4.10%		4.10%

Condensed Consolidating Finan81

Condensed Consolidating Financial Statements (Condensed Consolidating Statements of Operations and Comprehensive Income) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Revenues
Net sales	$ 208,770	$ 191,287
Other revenues	805	845
Total revenues	209,575	192,132
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	87,984	79,896
Gross profit	121,591	112,236
Operating Expenses
Advertising and promotion	27,635	26,422
General and administrative	19,457	17,589
Depreciation and amortization	6,832	5,720
Loss on sale of assets	55,453	0
Total operating expenses	109,377	49,731
Operating income	12,214	62,505
Other (income) expense
Interest income	(57)	(27)
Interest expense	21,184	21,911
Loss on extinguishment of debt	0	451
Equity in (income) loss of subsidiaries	0	0
Total other expense (income)	21,127	22,335
(Loss) income before income taxes	(8,913)	40,170
(Benefit) provision for income taxes	(3,382)	13,997
Net (loss) income	(5,531)	26,173
Comprehensive (loss) income, net of tax:
Currency translation adjustments	(5,824)	(405)
Total other comprehensive loss	(5,824)	(405)
Comprehensive (loss) income	(11,355)	25,768
Prestige Brands Holdings, Inc.
Revenues
Net sales	0	0
Other revenues	0	0
Total revenues	0	0
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	0	0
Gross profit	0	0
Operating Expenses
Advertising and promotion	0	0
General and administrative	1,937	1,315
Depreciation and amortization	920	989
Loss on sale of assets	0
Total operating expenses	2,857	2,304
Operating income	(2,857)	(2,304)
Other (income) expense
Interest income	(11,967)	(12,049)
Interest expense	8,440	8,490
Loss on extinguishment of debt		0
Equity in (income) loss of subsidiaries	5,738	(25,306)
Total other expense (income)	2,211	(28,865)
(Loss) income before income taxes	(5,068)	26,561
(Benefit) provision for income taxes	463	388
Net (loss) income	(5,531)	26,173
Comprehensive (loss) income, net of tax:
Currency translation adjustments	(5,824)	(405)
Total other comprehensive loss	(5,824)	(405)
Comprehensive (loss) income	(11,355)	25,768
Prestige Brands, Inc., the issuer
Revenues
Net sales	27,959	27,883
Other revenues	75	96
Total revenues	28,034	27,979
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	12,086	10,441
Gross profit	15,948	17,538
Operating Expenses
Advertising and promotion	4,745	2,517
General and administrative	2,188	2,555
Depreciation and amortization	151	146
Loss on sale of assets	0
Total operating expenses	7,084	5,218
Operating income	8,864	12,320
Other (income) expense
Interest income	(21,262)	(21,408)
Interest expense	21,174	21,908
Loss on extinguishment of debt		451
Equity in (income) loss of subsidiaries	(31,333)	(16,955)
Total other expense (income)	(31,421)	(16,004)
(Loss) income before income taxes	40,285	28,324
(Benefit) provision for income taxes	3,178	4,025
Net (loss) income	37,107	24,299
Comprehensive (loss) income, net of tax:
Currency translation adjustments	(5,824)	(405)
Total other comprehensive loss	(5,824)	(405)
Comprehensive (loss) income	31,283	23,894
Combined Subsidiary Guarantors
Revenues
Net sales	168,205	152,524
Other revenues	801	819
Total revenues	169,006	153,343
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	71,462	66,378
Gross profit	97,544	86,965
Operating Expenses
Advertising and promotion	20,804	21,228
General and administrative	14,314	11,951
Depreciation and amortization	5,633	4,445
Loss on sale of assets	55,453
Total operating expenses	96,204	37,624
Operating income	1,340	49,341
Other (income) expense
Interest income	(1,274)	(1,220)
Interest expense	24,901	25,055
Loss on extinguishment of debt		0
Equity in (income) loss of subsidiaries	(3,076)	(1,450)
Total other expense (income)	20,551	22,385
(Loss) income before income taxes	(19,211)	26,956
(Benefit) provision for income taxes	(7,912)	9,029
Net (loss) income	(11,299)	17,927
Comprehensive (loss) income, net of tax:
Currency translation adjustments	(5,824)	(405)
Total other comprehensive loss	(5,824)	(405)
Comprehensive (loss) income	(17,123)	17,522
Combined Non- Guarantor Subsidiaries
Revenues
Net sales	13,826	11,608
Other revenues	486	498
Total revenues	14,312	12,106
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	6,000	4,408
Gross profit	8,312	7,698
Operating Expenses
Advertising and promotion	2,086	2,677
General and administrative	1,018	1,768
Depreciation and amortization	128	140
Loss on sale of assets	0
Total operating expenses	3,232	4,585
Operating income	5,080	3,113
Other (income) expense
Interest income	(159)	(112)
Interest expense	1,274	1,220
Loss on extinguishment of debt		0
Equity in (income) loss of subsidiaries	0	0
Total other expense (income)	1,115	1,108
(Loss) income before income taxes	3,965	2,005
(Benefit) provision for income taxes	889	555
Net (loss) income	3,076	1,450
Comprehensive (loss) income, net of tax:
Currency translation adjustments	(5,824)	(405)
Total other comprehensive loss	(5,824)	(405)
Comprehensive (loss) income	(2,748)	1,045
Eliminations
Revenues
Net sales	(1,220)	(728)
Other revenues	(557)	(568)
Total revenues	(1,777)	(1,296)
Cost of Sales
Cost of sales (exclusive of depreciation shown below)	(1,564)	(1,331)
Gross profit	(213)	35
Operating Expenses
Advertising and promotion	0	0
General and administrative	0	0
Depreciation and amortization	0	0
Loss on sale of assets	0
Total operating expenses	0	0
Operating income	(213)	35
Other (income) expense
Interest income	34,605	34,762
Interest expense	(34,605)	(34,762)
Loss on extinguishment of debt		0
Equity in (income) loss of subsidiaries	28,671	43,711
Total other expense (income)	28,671	43,711
(Loss) income before income taxes	(28,884)	(43,676)
(Benefit) provision for income taxes	0	0
Net (loss) income	(28,884)	(43,676)
Comprehensive (loss) income, net of tax:
Currency translation adjustments	17,472	1,215
Total other comprehensive loss	17,472	1,215
Comprehensive (loss) income	$ (11,412)	$ (42,461)

Condensed Consolidating Finan82

Condensed Consolidating Financial Statements (Condensed Consolidating Balance Sheet) (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2015	Mar. 31, 2015
Current assets
Cash and cash equivalents	$ 28,877	$ 27,230	$ 21,598	$ 21,318
Accounts receivable, net	88,437	95,247
Inventories	92,867	91,263
Deferred income tax assets	10,702	10,108
Prepaid expenses and other current assets	18,730	25,165
Assets held for sale	41,745	0
Total current assets	281,358	249,013
Property and equipment, net	15,080	15,540
Goodwill	356,525	360,191
Intangible assets, net	2,223,559	2,322,723
Other long-term assets	1,918	1,324
Intercompany receivables	0	0
Investment in subsidiary	0	0
Total Assets	2,878,440	2,948,791
Current liabilities
Accounts payable	35,012	38,296
Accrued interest payable	9,216	8,664
Other accrued liabilities	55,913	59,724
Total current liabilities	100,141	106,684
Long-term debt
Principal amount	1,602,500	1,652,500
Less unamortized debt costs	(25,086)	(27,191)
Long-term debt, net	1,577,414	1,625,309
Deferred income tax liabilities	460,557	469,622
Other long-term liabilities	2,847	2,840
Intercompany payables	0	0
Total Liabilities	2,140,959	2,204,455
Stockholders' Equity
Common stock	532	530
Additional paid-in capital	451,075	445,182
Treasury stock, at cost	(6,558)	(5,163)
Accumulated other comprehensive (loss) income, net of tax	(29,349)	(23,525)
Retained earnings (accumulated deficit)	321,781	327,312
Total Stockholders' Equity	737,481	744,336
Total Liabilities and Stockholders' Equity	2,878,440	2,948,791
Prestige Brands Holdings, Inc.
Current assets
Cash and cash equivalents	5,311	4,440	10,832	11,387
Accounts receivable, net	0	0
Inventories	0	0
Deferred income tax assets	325	316
Prepaid expenses and other current assets	9,012	15,311
Assets held for sale	0
Total current assets	14,648	20,067
Property and equipment, net	8,624	9,166
Goodwill	0	0
Intangible assets, net	0	0
Other long-term assets	0	0
Intercompany receivables	1,460,733	1,457,011
Investment in subsidiary	1,631,033	1,641,477
Total Assets	3,115,038	3,127,721
Current liabilities
Accounts payable	1,384	2,914
Accrued interest payable	0	0
Other accrued liabilities	7,991	12,285
Total current liabilities	9,375	15,199
Long-term debt
Principal amount	0	0
Less unamortized debt costs	0	0
Long-term debt, net	0	0
Deferred income tax liabilities	0	0
Other long-term liabilities	0	0
Intercompany payables	2,368,182	2,368,186
Total Liabilities	2,377,557	2,383,385
Stockholders' Equity
Common stock	532	530
Additional paid-in capital	451,075	445,182
Treasury stock, at cost	(6,558)	(5,163)
Accumulated other comprehensive (loss) income, net of tax	(29,349)	(23,525)
Retained earnings (accumulated deficit)	321,781	327,312
Total Stockholders' Equity	737,481	744,336
Total Liabilities and Stockholders' Equity	3,115,038	3,127,721
Prestige Brands, Inc., the issuer
Current assets
Cash and cash equivalents	0	0	0	0
Accounts receivable, net	10,167	12,025
Inventories	10,017	9,411
Deferred income tax assets	826	681
Prepaid expenses and other current assets	538	257
Assets held for sale	0
Total current assets	21,548	22,374
Property and equipment, net	216	210
Goodwill	66,007	66,007
Intangible assets, net	191,655	191,789
Other long-term assets	1,918	1,324
Intercompany receivables	2,664,832	2,703,192
Investment in subsidiary	1,553,227	1,527,718
Total Assets	4,499,403	4,512,614
Current liabilities
Accounts payable	6,922	7,643
Accrued interest payable	9,216	8,664
Other accrued liabilities	2,137	1,714
Total current liabilities	18,275	18,021
Long-term debt
Principal amount	1,602,500	1,652,500
Less unamortized debt costs	(25,086)	(27,191)
Long-term debt, net	1,577,414	1,625,309
Deferred income tax liabilities	60,847	60,317
Other long-term liabilities	0	0
Intercompany payables	1,243,701	1,241,084
Total Liabilities	2,900,237	2,944,731
Stockholders' Equity
Common stock	0	0
Additional paid-in capital	1,280,947	1,280,947
Treasury stock, at cost	0	0
Accumulated other comprehensive (loss) income, net of tax	(29,349)	(23,525)
Retained earnings (accumulated deficit)	347,568	310,461
Total Stockholders' Equity	1,599,166	1,567,883
Total Liabilities and Stockholders' Equity	4,499,403	4,512,614
Combined Subsidiary Guarantors
Current assets
Cash and cash equivalents	2,278	2,899	0	0
Accounts receivable, net	69,646	74,446
Inventories	73,711	72,296
Deferred income tax assets	8,812	8,293
Prepaid expenses and other current assets	8,365	8,379
Assets held for sale	41,745
Total current assets	204,557	166,313
Property and equipment, net	5,641	5,528
Goodwill	268,490	271,409
Intangible assets, net	1,946,309	2,042,640
Other long-term assets	0	0
Intercompany receivables	1,249,875	1,083,488
Investment in subsidiary	77,679	81,545
Total Assets	3,752,551	3,650,923
Current liabilities
Accounts payable	24,731	24,437
Accrued interest payable	0	0
Other accrued liabilities	39,617	38,734
Total current liabilities	64,348	63,171
Long-term debt
Principal amount	0	0
Less unamortized debt costs	0	0
Long-term debt, net	0	0
Deferred income tax liabilities	399,323	408,893
Other long-term liabilities	2,682	2,682
Intercompany payables	1,697,409	1,570,265
Total Liabilities	2,163,762	2,045,011
Stockholders' Equity
Common stock	0	0
Additional paid-in capital	1,359,921	1,359,921
Treasury stock, at cost	0	0
Accumulated other comprehensive (loss) income, net of tax	(29,349)	(23,525)
Retained earnings (accumulated deficit)	258,217	269,516
Total Stockholders' Equity	1,588,789	1,605,912
Total Liabilities and Stockholders' Equity	3,752,551	3,650,923
Combined Non- Guarantor Subsidiaries
Current assets
Cash and cash equivalents	21,288	19,891	10,766	9,931
Accounts receivable, net	8,624	8,776
Inventories	9,884	10,088
Deferred income tax assets	739	818
Prepaid expenses and other current assets	815	1,218
Assets held for sale	0
Total current assets	41,350	40,791
Property and equipment, net	599	636
Goodwill	22,028	22,775
Intangible assets, net	85,595	88,294
Other long-term assets	0	0
Intercompany receivables	11,046	10,738
Investment in subsidiary	0	0
Total Assets	160,618	163,234
Current liabilities
Accounts payable	1,975	3,302
Accrued interest payable	0	0
Other accrued liabilities	6,168	6,991
Total current liabilities	8,143	10,293
Long-term debt
Principal amount	0	0
Less unamortized debt costs	0	0
Long-term debt, net	0	0
Deferred income tax liabilities	387	412
Other long-term liabilities	165	158
Intercompany payables	77,194	74,894
Total Liabilities	85,889	85,757
Stockholders' Equity
Common stock	0	0
Additional paid-in capital	78,774	78,774
Treasury stock, at cost	0	0
Accumulated other comprehensive (loss) income, net of tax	(29,349)	(23,525)
Retained earnings (accumulated deficit)	25,304	22,228
Total Stockholders' Equity	74,729	77,477
Total Liabilities and Stockholders' Equity	160,618	163,234
Eliminations
Current assets
Cash and cash equivalents	0	0	$ 0	$ 0
Accounts receivable, net	0	0
Inventories	(745)	(532)
Deferred income tax assets	0	0
Prepaid expenses and other current assets	0	0
Assets held for sale	0
Total current assets	(745)	(532)
Property and equipment, net	0	0
Goodwill	0	0
Intangible assets, net	0	0
Other long-term assets	0	0
Intercompany receivables	(5,386,486)	(5,254,429)
Investment in subsidiary	(3,261,939)	(3,250,740)
Total Assets	(8,649,170)	(8,505,701)
Current liabilities
Accounts payable	0	0
Accrued interest payable	0	0
Other accrued liabilities	0	0
Total current liabilities	0	0
Long-term debt
Principal amount	0	0
Less unamortized debt costs	0	0
Long-term debt, net	0	0
Deferred income tax liabilities	0	0
Other long-term liabilities	0	0
Intercompany payables	(5,386,486)	(5,254,429)
Total Liabilities	(5,386,486)	(5,254,429)
Stockholders' Equity
Common stock	0	0
Additional paid-in capital	(2,719,642)	(2,719,642)
Treasury stock, at cost	0	0
Accumulated other comprehensive (loss) income, net of tax	88,047	70,575
Retained earnings (accumulated deficit)	(631,089)	(602,205)
Total Stockholders' Equity	(3,262,684)	(3,251,272)
Total Liabilities and Stockholders' Equity	$ (8,649,170)	$ (8,505,701)

Condensed Consolidating Finan83

Condensed Consolidating Financial Statements (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Operating Activities
Net (loss) income	$ (5,531)	$ 26,173
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	6,832	5,720
Gain on sale of asset	55,453	(36)
Deferred income taxes	(9,660)	11,536
Amortization of debt origination costs	2,231	2,138
Stock-based compensation costs	1,940	3,047
Loss on extinguishment of debt	0	451
Equity in income of subsidiaries	0	0
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	5,151	2,578
Inventories	(4,327)	(211)
Prepaid expenses and other current assets	5,697	(1,522)
Accounts payable	(3,401)	783
Accrued liabilities	(3,634)	(7,136)
Net cash provided by operating activities	50,751	43,521
Investing Activities
Purchases of property and equipment	(895)	(780)
Proceeds from the sale of property and equipment	0	344
Net cash used in investing activities	(895)	(436)
Financing Activities
Term loan repayments	(50,000)	(25,000)
Borrowings under revolving credit agreement	0	15,000
Repayments under revolving credit agreement	0	(35,000)
Payments of debt origination costs	(9)	(4,172)
Proceeds from exercise of stock options	3,405	6,328
Proceeds from restricted stock exercises	0	544
Excess tax benefits from share-based awards	550	1,600
Fair value of shares surrendered as payment of tax withholding	(1,395)	(2,187)
Intercompany activity, net	0	0
Net cash used in financing activities	(47,449)	(42,887)
Effects of exchange rate changes on cash and cash equivalents	(760)	82
Increase (decrease) in cash and cash equivalents	1,647	280
Cash and cash equivalents - beginning of period	27,230	21,318
Cash and cash equivalents - end of period	28,877	21,598
Prestige Brands Holdings, Inc.
Operating Activities
Net (loss) income	(5,531)	26,173
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	920	989
Gain on sale of asset	0	0
Deferred income taxes	(9)	141
Amortization of debt origination costs	0	0
Stock-based compensation costs	1,940	3,047
Loss on extinguishment of debt		0
Equity in income of subsidiaries	5,738	(25,306)
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	0	0
Inventories	0	0
Prepaid expenses and other current assets	6,299	(2,152)
Accounts payable	(1,556)	861
Accrued liabilities	(4,294)	(5,668)
Net cash provided by operating activities	3,507	(1,915)
Investing Activities
Purchases of property and equipment	(225)	(648)
Proceeds from the sale of property and equipment		0
Net cash used in investing activities	(225)	(648)
Financing Activities
Term loan repayments	0	0
Borrowings under revolving credit agreement		0
Repayments under revolving credit agreement		0
Payments of debt origination costs	0	0
Proceeds from exercise of stock options	3,405	6,328
Proceeds from restricted stock exercises		544
Excess tax benefits from share-based awards	550	1,600
Fair value of shares surrendered as payment of tax withholding	(1,395)	(2,187)
Intercompany activity, net	(4,971)	(4,277)
Net cash used in financing activities	(2,411)	2,008
Effects of exchange rate changes on cash and cash equivalents	0	0
Increase (decrease) in cash and cash equivalents	871	(555)
Cash and cash equivalents - beginning of period	4,440	11,387
Cash and cash equivalents - end of period	5,311	10,832
Prestige Brands, Inc., the issuer
Operating Activities
Net (loss) income	37,107	24,299
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	151	146
Gain on sale of asset	0	0
Deferred income taxes	385	395
Amortization of debt origination costs	2,231	2,138
Stock-based compensation costs	0	0
Loss on extinguishment of debt		451
Equity in income of subsidiaries	(31,333)	(16,955)
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	1,858	3,171
Inventories	(606)	1,175
Prepaid expenses and other current assets	(281)	(102)
Accounts payable	(721)	(325)
Accrued liabilities	975	(2,368)
Net cash provided by operating activities	9,766	12,025
Investing Activities
Purchases of property and equipment	(23)	0
Proceeds from the sale of property and equipment		0
Net cash used in investing activities	(23)	0
Financing Activities
Term loan repayments	(50,000)	(25,000)
Borrowings under revolving credit agreement		15,000
Repayments under revolving credit agreement		(35,000)
Payments of debt origination costs	(9)	(4,172)
Proceeds from exercise of stock options	0	0
Proceeds from restricted stock exercises		0
Excess tax benefits from share-based awards	0	0
Fair value of shares surrendered as payment of tax withholding	0	0
Intercompany activity, net	40,266	37,147
Net cash used in financing activities	(9,743)	(12,025)
Effects of exchange rate changes on cash and cash equivalents	0	0
Increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents - beginning of period	0	0
Cash and cash equivalents - end of period	0	0
Combined Subsidiary Guarantors
Operating Activities
Net (loss) income	(11,299)	17,927
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	5,633	4,445
Gain on sale of asset	55,453	0
Deferred income taxes	(10,089)	10,866
Amortization of debt origination costs	0	0
Stock-based compensation costs	0	0
Loss on extinguishment of debt		0
Equity in income of subsidiaries	(3,076)	(1,450)
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	4,800	735
Inventories	(3,835)	(1,457)
Prepaid expenses and other current assets	(697)	722
Accounts payable	109	880
Accrued liabilities	261	975
Net cash provided by operating activities	37,260	33,643
Investing Activities
Purchases of property and equipment	(596)	(27)
Proceeds from the sale of property and equipment		0
Net cash used in investing activities	(596)	(27)
Financing Activities
Term loan repayments	0	0
Borrowings under revolving credit agreement		0
Repayments under revolving credit agreement		0
Payments of debt origination costs	0	0
Proceeds from exercise of stock options	0	0
Proceeds from restricted stock exercises		0
Excess tax benefits from share-based awards	0	0
Fair value of shares surrendered as payment of tax withholding	0	0
Intercompany activity, net	(37,285)	(33,616)
Net cash used in financing activities	(37,285)	(33,616)
Effects of exchange rate changes on cash and cash equivalents	0	0
Increase (decrease) in cash and cash equivalents	(621)	0
Cash and cash equivalents - beginning of period	2,899	0
Cash and cash equivalents - end of period	2,278	0
Combined Non- Guarantor Subsidiaries
Operating Activities
Net (loss) income	3,076	1,450
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	128	140
Gain on sale of asset	0	(36)
Deferred income taxes	53	134
Amortization of debt origination costs	0	0
Stock-based compensation costs	0	0
Loss on extinguishment of debt		0
Equity in income of subsidiaries	0	0
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	(1,507)	(1,328)
Inventories	(99)	106
Prepaid expenses and other current assets	376	10
Accounts payable	(1,233)	(633)
Accrued liabilities	(576)	(75)
Net cash provided by operating activities	218	(232)
Investing Activities
Purchases of property and equipment	(51)	(105)
Proceeds from the sale of property and equipment		344
Net cash used in investing activities	(51)	239
Financing Activities
Term loan repayments	0	0
Borrowings under revolving credit agreement		0
Repayments under revolving credit agreement		0
Payments of debt origination costs	0	0
Proceeds from exercise of stock options	0	0
Proceeds from restricted stock exercises		0
Excess tax benefits from share-based awards	0	0
Fair value of shares surrendered as payment of tax withholding	0	0
Intercompany activity, net	1,990	746
Net cash used in financing activities	1,990	746
Effects of exchange rate changes on cash and cash equivalents	(760)	82
Increase (decrease) in cash and cash equivalents	1,397	835
Cash and cash equivalents - beginning of period	19,891	9,931
Cash and cash equivalents - end of period	21,288	10,766
Eliminations
Operating Activities
Net (loss) income	(28,884)	(43,676)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	0	0
Gain on sale of asset	0	0
Deferred income taxes	0	0
Amortization of debt origination costs	0	0
Stock-based compensation costs	0	0
Loss on extinguishment of debt		0
Equity in income of subsidiaries	28,671	43,711
Changes in operating assets and liabilities, net of effects from acquisitions
Accounts receivable	0	0
Inventories	213	(35)
Prepaid expenses and other current assets	0	0
Accounts payable	0	0
Accrued liabilities	0	0
Net cash provided by operating activities	0	0
Investing Activities
Purchases of property and equipment	0	0
Proceeds from the sale of property and equipment		0
Net cash used in investing activities	0	0
Financing Activities
Term loan repayments	0	0
Borrowings under revolving credit agreement		0
Repayments under revolving credit agreement		0
Payments of debt origination costs	0	0
Proceeds from exercise of stock options	0	0
Proceeds from restricted stock exercises		0
Excess tax benefits from share-based awards	0	0
Fair value of shares surrendered as payment of tax withholding	0	0
Intercompany activity, net	0	0
Net cash used in financing activities	0	0
Effects of exchange rate changes on cash and cash equivalents	0	0
Increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents - beginning of period	0	0
Cash and cash equivalents - end of period	$ 0	$ 0

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details) $ in Thousands	Aug. 02, 2016shares	Jul. 07, 2016USD ($)	Jun. 30, 2016USD ($)	May 26, 2016shares	May 09, 2016shares	Aug. 04, 2015shares	May 11, 2015shares	Dec. 31, 2014USD ($)	Sep. 30, 2016USD ($)	Jun. 30, 2016shares	Jun. 30, 2015shares
Restricted Stock Units (RSUs)
Subsequent Event [Line Items]
Granted in period to each independent director (in shares) | shares					49,064	2,075				49,400	243,800
Period following director's term in which RSUs may be settled						6 months
Restricted Stock Units (RSUs) | Subsequent Event
Subsequent Event [Line Items]
Granted in period to each independent director (in shares) | shares	1,896
Period following director's term in which RSUs may be settled	6 months
Director | Restricted Stock Units (RSUs)
Subsequent Event [Line Items]
Granted in period to each independent director (in shares) | shares				346			362
Number of common shares into which each RSU may be converted (in shares) | shares						1
Director | Restricted Stock Units (RSUs) | Subsequent Event
Subsequent Event [Line Items]
Number of common shares into which each RSU may be converted (in shares) | shares	1
Comet Brand
Subsequent Event [Line Items]
Proceeds from sale of rights to Comet brand | $			$ 1,000					$ 10,000
Comet Brand | Scenario, Forecast
Subsequent Event [Line Items]
Royalty revenue, increase (decrease) due to amended royalty agreement | $									$ (800)
Disposed of by Sale | Pediacare, New Skin and Fiber Choice | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | North American OTC Healthcare
Subsequent Event [Line Items]
Pre-tax loss on divestiture | $			$ 55,500
Disposed of by Sale | Pediacare, New Skin and Fiber Choice | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | North American OTC Healthcare | Subsequent Event
Subsequent Event [Line Items]
Proceeds from the sale divestiture | $		$ 40,100
Disposed of by Sale | Dermoplast | Cough and Cold, Dermatologicals, and Gastrointestinal Products Group | North American OTC Healthcare | Subsequent Event
Subsequent Event [Line Items]
Deposit for agreement to purchase | $		$ 1,250
Deposit expiration period from closing		90 days